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Abstract 
 Nucleolin is a nucleolar protein important for ribosome biogenesis.  Nucleolin 
contains a conserved glycine arginine rich (GAR) domain near its carboxy terminus.  
GAR domains are defined by repeating tri-peptide, (arginine -glycine-glycine (RGG)) 
motifs.  The arginine in the RGG motif is post-translationally modified by dimethylation 
on one of the two guanido nitrogens.  Although arginine methylation was identified over 
30 years ago, the function of this modification remains unknown.  The GAR domain of 
nucleolin is important for nucleic acid binding and for nucleolar localization of nucleolin.  
This dissertation describes investigates possible in vivo interactions between nucleolin 
and other nucleolar proteins involved in ribosome biogenesis.  This dissertation also 
addresses the possible roles that arginine dimethylation may play in the function of the 
GAR domain. 
 A GAR truncated hamster nucleolin (∆GAR) localizes to the nucleoplasm and not 
to the nucleoli of CHO cells.  This version of nucleolin was subsequently used to probe 
the in vivo interactions of nucleolin with other non-ribosomal nucleolar proteins.  In 
support of previous work, ∆GAR caused endogenous B23 to redistribute to the 
nucleoplasm, suggesting an in vivo interaction.  Endogenous Nopp140 shows no 
redistribution in the presence of ∆GAR.  The effect of ∆GAR on the nucleolar protein, 
fibrillarin, remains unclear. 
 A redistribution of exogenously expressed wild type nucleolin from nucleoli to 
the nucleoplasm is observed when CHO cells are treated with the methyltransferase 
inhibitors 5-methyl 5′ deoxythioadenosine (MTA) and 3-deaza-adenosine (DAA).  This 
redistribution of nucleolin is reversible and independent of protein synthesis. 
 viii 
 The arginines in the RGG motifs of the GAR domain of hamster nucleolin were 
changed to lysine, and the fully substituted protein was not a substrate for the RGG 
specific protein arginine methyltransferase, Hmt1p.  The lysine substituted protein bound 
nucleic acids and behaved in vivo in a manner indistinguishable from wild type nucleolin.  
These results indicate that methylation is not necessary for in vitro nucleic acid binding 
or for in vivo localization of nucleolin, and that the redistribution of nucleolin observed 
following MTA treatment is likely due to inhibiting the methylation of another nucleolar 




 Literature Review  
 Ribosomes are the biosynthetic engines that, convert the static sum of evolution in 
the form of DNA and its RNA intermediary into dynamic proteins that catalyze the 
unusual chemical reaction known as life.  Eukaryotic ribosomes are perhaps the most 
complex macromolecular assemblies.  They consist of four precisely folded and modified 
RNAs and over eighty different ribosomal proteins.  The ribosome consists of two 
subunits that come together to form the functional complex.  Protein synthesis 
requirements of the cell are dependent on ribosomes; it is therefore logical that ribosome 
biogenesis is regulated with regards to the metabolic state of the cell as well as its stage 
in the cell cycle.  To successfully assemble this complex, transcription of the ribosomal 
RNAs and production of ribosomal proteins, as well as proteins involved in processing 
and assembly, must all be finely coordinated and brought to bear at the correct time and 
place.  An actively growing HeLa cell, for example, synthesizes around 7500 ribosomal 
subunits per minute, using up to 300,000 ribosomal proteins in their assembly.  Before 
assembly of the rRNA with these proteins, each pre-rRNA interacts with almost 150 
different species of small nucleolar RNAs that guide various post-transcriptional 
modifications and cleavages. The site of all this activity is the nucleolus.  In addition to 
its long standing role in ribosome biogenesis, the nucleolus has new potential functions, 
including post-translational RNA modification, ribonucleoparticle assembly, gene 
silencing, aging and cell cycle control (reviewed by Hadjiolov, 1985, Schwarzacher and 
Wachtler,  1993; Mélèse and Xue, 1995; Shaw and Jordan 1995; Jordan, 1987; Pederson, 
1998a; Pederson, 1998b, Garcia and Pillus, 1999; Lewis and Tollervey, 2000; Pederson, 
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2000, Schwarzacher and Mosgoelier, 2000; Olson et al., 2000; Dundr and Misteli, 2001; 
Leary and Huang, 2001). 
THE NUCLEOLUS 
Due to its prominence when visualized by light microscopy, the nucleolus was 
one of the first sub-nuclear structures to be described by Fontana in 1774 and by R. 
Wagner, G. Valentin, and M. Schleiden between 1835-1838 (Miller, 1981).  Its 
prominence is due to a very high protein concentration, which is typically the highest 
concentration in the cell.  The number and shape of nucleoli vary depending on species, 
cell type, location in the cell cycle, and metabolic state of the cell (Hadjiolov, 1985).  
Nucleoli are not deliminted by a membrane; their existence appears to be the result of 
associations of components needed for ribosome biogenesis (Mélèse and Xue, 1995).  
The metazoan nucleolus is morphologically separated into three distinct concentric 
components, the inner fibrillar center (FC), the middle dense fibrillar component (DFC), 
and the outer granular component (GC).  This concentric morphology of the nucleolus 
reflects the vectorial process of ribosome biogenesis.  
Structure 
 The morphology of the nucleolus varies depending on the organism, the cell type, 
and the location in the cell cycle.  These differences are mainly associated with the 
metabolic state of the cell and its need for ribosomes.  Quiescent cells usually have one 
compact nucleolus, typified by well defined concentric sub-domains.  Active cells often 
have multiple nucleoli, that become larger and reticulated with increased metabolism 
(Schwarzacher and Mosgoelier, 2000).           
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 The nucleolus is the location of tandemly repeated ribosomal genes (rDNA 
genes) collectively known as the nucleolar organizer region (NOR).  Heitz (1931) and 
McClintock (1934) established the NOR as a genetically determined element on mitotic 
chromosomes that gave rise to interphase nucleoli.  NORs were first identified as 
secondary constrictions present in the mitotic chromosomes that appeared to correspond 
to reforming nucleoli in teleophase in Zea mays (McClintock, 1934).  The tandemly 
repeated arrays of ribosomal genes in the form of condensed mitotic chromatin are 
located on several “nucleolar chromosomes,” usually near one of the two telomeres.   
The metazoan ribosomal DNA repeating transcription unit from 5′ to 3′ consists 
of an external transcribed spacer (ETS), 18S rDNA, internal transcribed spacer 1 (ITS 1), 
5.8S rDNA, internal transcribed spacer 2 (ITS 2), 28S rDNA, all followed by an 
intergenic spacer region (IGS).  The 5S rDNA gene lies within this same repeating unit in 
budding yeast, but 5′ to the main rDNA gene.  However, it is transcribed in the opposite 
orientation by RNA polymerase III rather than by RNA polymerase I.  The 5S rDNA 
genes in metazoans are usually located on “non-nucleolar” chromosomes, and they are 
transcribed by RNA polymerase III. Transcription of the 5S rRNA is usually positioned 
in close proximity to the nucleolus, presumably to allow quick transport of the RNA to 
the nucleolus (Hadjiolov, 1985; Schwarzacher and Wachtler, 1993). 
 In interphase cells the fibrillar center appears as a light region under phase-
contrast microscopy.  Under electron microscopy, the FC appears as a meshwork of fine 
fibrils, 4-5 nm thick.  The shape of the fibrils is roughly globular.  FCs vary in size from 
50 nm to 1 µm.  In quiescent cells with a compact nucleolus, there is one FC.  As cells 
become active, however, multiple FCs become visible, but they eventually disappear 
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altogether, possibly as the result of chromatin decondensation and a release of 
transcription factors from the FC to accommodate the increased transcriptional 
requirements.  Although some suggest that active transcription does not occurr in the FC, 
transcription machinery including RNA polymerase I, upstream binding factor (UBF), 
selectivity factor 1 (SL1), topoisomerase I, DNA helicases and other factors related to 
transcription are localized to the FCs (Scheer and Rose, 1984; Rose et al., 1988, Jordan et 
al., 1996; Voit et al., 1995; Zirwes et al., 2000).  
The DFC associates with or surrounds the FC.  Early work indicated that the FC is 
the site of active ribosomal RNA transcription, but recent high resolution in situ 
hybridization with a 5'-ETS probe and Br-UTP incorporation studies reveal that active 
rDNA genes reside on the periphery of the fibrillar centers and are excluded from their 
interiors.  The results localized rDNA transcription to the DFC, or at least to FC-DFC 
boarder (Thiry et al., 1992; Hozák et al., 1994; Puvion-Dutilleul et al., 1997; Mosgoeller 
et al., 1998; Cmarko et al., 1999; reviewed by Scheer and Hock, 1999; Raska et al., 
1992).  However, the debate over the site of ribosomal RNA transcription is still 
questioned by some (Mais and Scheer, 2000).    
Processing cleavages leading to the formation of the mature 18S, 5.8S, and 28S 
rRNAs begin in the DFC.  Post-transcriptional modifications such as pseudouridine 
synthesis and 2′-O-methylation of rRNA also occur in the DFCs (Nicoloso et al., 1996; 
Shaw and Jordan, 1995).  Like the FC, the DFC consists of very fine fibrils of 3-5 nm in 
thickness, but the fibrils are very densely packed together giving them high electron 
microscopic contrast.  In very active nucleoli, the fibrils appear to form sheets termed 
nucleolonema.  The nucleolonema has been observed to possibly form a path for pre-
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ribosomal particles within the nucleolus (Ghosh and Paweletz, 1996). The size of the 
DFC is usually directly related to nucleolar activity (Schwarzacher and Wachtler, 1993). 
The GC is located at the periphery of the nucleolus and intermingles with the 
DFC.  The GC is the site of maturing pre-ribosomal particles, consisting of small 
granules that measure 10-20 nm in diameter.  Processing cleavages and post-translational 
modifications, along with assembly of ribosomal proteins onto rRNA that started in the 
DFC, are completed in the GC (Schwarzacher and Wachtler, 1993).  In summary, the 
rRNA in the form of pre-ribosomal particles moves through the DFC to the GC by radial 
flow from the site of its transcription (Lazdins et al., 1997; Thiry et al., 2000). 
When transcription of rRNA is inhibited by actinomyosin D or by the onset of 
mitosis, metazoan nucleoli disassemble, indicating the need for active transcription to 
maintain nucleolar morphology (Phillips and Phillips, 1971; Recher et al., 1971; Scheer 
et al., 1975; Noel et al., 1971; Ploton et al., 1987; Weisenberger and Scheer, 1995; Dundr 
et al., 2000).  Ectopic expression of rDNA in Drosophila resulted in the formation of 
nucleoplasmic micronucleoli (Karpen et al., 1988).  The same was true for transcription 
of rRNA from a polymerase II promoter on a replicating plasmid in yeast (Oakes et al., 
1998).  These micronucleoli are able to produce functional ribosomes in the absence of 
morphologically normal nucleoli, supporting the idea that nucleoli are the result of 
associations of proteins and RNAs needed for ribosome biogenesis.   
The disassembly of metazoan nucleoli at the onset of mitosis is accompanied by 
hyperphosphorylation of many of the non-ribosomal nucleolar proteins that are involved 
in ribosome biogenesis.  Once phosphorylated by mitosis specific kinases (e.g. cyclin-
dependent kinase I (CDK1)), the nucleolar proteins redistribute to the cytoplasm. RNA 
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polymerase I transcription is also halted in mitosis.  The polymerase I transcription 
machinery, however, remains associated with the NORs during mitosis (Scheer and Rose, 
1984; Roussel et al., 1996).  Inhibition of polymerase I is mediated by CDK1; blocking 
CDK1 activity induces resumption of rDNA transcription in mitotic cells.  Primary 
transcripts synthesized in mitosis remain unprocessed, thus indicating an independent 
mechanism for resumption of rRNA processing (Sirri et al., 2000).  In contrast, partially 
processed pre-rRNA is found associated with a number of processing components, 
localized to the perichromosomal layer during mitosis, or in numerous large aggregates 
known as nucleolus derived foci (NDF) that are distributed throughout the mitotic 
cytoplasm (Ochs et al., 1985; Azum-Gélade et al., 1994; Pai et al., 1995; Dundr and 
Olson, 1998; Fomproix et al., 1998; Dundr et al., 2000).   
In late anaphase, RNA polymerase I activity resumes, and pre-nucleolar bodies 
(PNBs) form as the processing components are released form the perichromosomal layer 
of decondensing chromosomes.  These PNBs are nucleated by partially processed pre-
rRNA.  PNBs do not coalesce to reform nucleoli as previously thought; live cell imaging 
indicates that PNBs act as stores of nucleolar components.  In teleophase the nucleolar 
components leave the PNBs and diffuse to nascent pre-rRNA transcripts at the re-
activated nucleolar organizers to thus reform nucleoli.  Interestingly, the order in which 
nucleolar components enter nucleoli corresponds to their position in the pre-rRNA 
processing pathway, reinforcing the idea presented by Mélèse and Xue (1995) that the 
nucleolus results from of the “act of building a ribosome”  (Dundr et al., 2000; Dundr and 
Misteli, 2001). 
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Although images of interphase nucleoli make them appear very stable, they are in 
fact very dynamic.  Proteins needed for pre-rRNA processing or ribosome assembly only 
transiently associate with nucleoli, and they exchange rapidly with the surrounding 
nucleoplasm.  Photobleaching experiments show that pre-RNA processing factors very 
rapidly exchange with the surrounding nucleoplasm.  Photobleaching has shown the 
mean residence time is less than forty seconds for the non-ribosomal nucleolar protein 
fibrillarin (see below), and presumably the box C/D class of snoRNA’s (see below) that 
associate with fibrillarin.  The steady state concentration of fibrillarin, however, is clearly 
nucleolar in interphase cells.  This is reflected by the fact that fibrillarin spends only four 
seconds in the nucleoplasm as compared to the roughly forty seconds in the nucleolus 
during a given cycle (Phair and Mistili, 2000; Snaar et al., 2000).  Similar results have 
also been shown for other factors involved in ribosome biogenesis, including nucleolin, 
B23, and RNase MRP.  In contrast, ribosomal proteins L9 and S5, are much slower in 
their nuclear mobilities (Chen and Huang, 2001).   A possible function for the cycling of 
nucleolar proteins could be to expose nucleolar proteins to the nuclear factors that 
regulate their activity (e.g. CDK1, casein kinase II (CKII) that are non-nucleolar in their 
localization.  
Function 
The major activity in the nucleolus is ribosome biogenesis.  This includes the 
transcription of ribosomal RNA, the subsequent processing of the 47S (mammalian form) 
primary transcript into the mature 18S, 5.8S and 28S ribosomal RNA’s, and the assembly 
with ribosomal proteins to form the pre-ribosomal particles that are then exported to the 
cytoplasm to form mature ribosomes.  Biogenesis of the ribosome is perhaps one of the 
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most complex pathways of ribonucleoparticle synthesis in the cell. In eukaryotes it 
involves a complex rRNA maturation pathway and the ordered assembly of about 80 
ribosomal proteins (see Fig. 1.1) (Hadjiolov, 1985).   
Ribosome biogenesis begins with transcription of the ribosomal RNA by RNA 
polymerase I.  Transcription in eukaryotes is a complex process requiring concerted 
interactions between multiple protein factors, DNA elements, and RNA polymerase I.  
The promoter sequences for the ribosomal genes show little homology to even relatively 
closely related species, presumable due to rapid rate of evolutionary changes brought 
about by gene conversion, unequal crossing over, and excision-integration events that are  
enhanced by the repetitive nature of the ribosomal genes.  These divergent promoter 
sequences are tolerated by a dedicated transcription machinery.  Although the specific 
sequences are not well conserved, the overall structural organization of rDNA promoters 
from eukaryotes is comparable.  The rDNA promoter consists of a start site proximal core 
promoter element (CPE) and distal elements, including the upstream control element 
(UCE), enhancers, terminators, and spacer promoters.  The CPE is sufficient for faithful 
transcription initiation, while upstream elements stimulate promoter activity without 
affecting transcriptional specificity (Haltiner et al., 1986; Windle and Sollner-Webb, 
1986; Mougey et al., 1996; reviewed by Grummt, 1999).   
The CPE (~ -10 to -40) upstream of the transcription initiation start site is the 
binding location for the pre-initiation complex.  First, promoter SL1 and UBF, bind to the 
CPE to recruit RNA polymerase I, as well as two polymerase I associated factors, TIF-1A 
and TIF-IC.  This forms a productive initiation complex.  Recent work by Ingrid 












Figure 1.1  Maturation of the eukaryotic ribosome.  Structural large (L) and small (S) proteins 
are added to the 45S rRNA to form the 80S preribosome.  The 55S preribosome is precursor to 
the mature 60S large ribosomal subparticle, and the 40S preribosome is precursor to the mature 
40S small ribosomal subunit.  Both the 60S and 40S particles are formed from the 80S 
preribosome through the addition of specific L and S proteins, respectively.  Adapted form 
Hadjiolov (1985). 
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RNA polymerase I synthesis during mitosis.  Inhibition begins in prophase and 
ends in late anaphase.  Grummt’s group showed that cdc2/cyclin B kinase (CDK1) 
phosphorylates SL1, impairing its interaction with UBF, and thus preventing formation of 
the pre-initiation complex (Heix et al., 1998; Kuhn et al., 1998).  Upstream enhancers 
seem to stimulate transcription via stabilization of the pre-initiation complex (Pape et al., 
1990; Xie and Rothblum, 1992). The RNA polymerase I initiation complex is stable for 
several rounds of transcription (Sollner-Webb and Mougey, 1991).  During mitosis, 
initiation complexes are believed to be primed on rDNA promoters awaiting 
decondensation of chromatin, which might loop out into the DFC to begin active 
transcription as mitosis draws to an end (Grummt, 1999).  Additional components such as 
topoisomerase I, single stranded binding protein (SSB), and helicases like NOH61 are 
present on the nucleolar organizer and needed for transcription (Zirwes et al., 2000; 
Weisenberger et al., 1993).    
The rate of rDNA transcription is regulated in accordance with cell growth, and 
the need for new ribosomes.  When cells approach a stationary phase or are serum-
starved, rDNA transcription is down-regulated.  Conversely, rDNA transcription is up- 
regulated upon reversal of such conditions (Buttgereit et al., 1985; Paule et al., 1984; 
Klein and Grummt, 1999).   
Further control of ribosome biogenesis is due in part to the interconnections 
between various nucleolar factors.  For example, several of the introns of pre-mRNAs 
that encode some ribosomal proteins as well as ribosome assembly factors like nucleolin 
(see below), contain snoRNAs needed for pre-rRNA processing (Caffarelli et al., 1994; 
Liang-Hu et al., 1995).  Subsequently, nucleolin is regulated by transcription factors such 
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as myc and myb, which are associated with cellular metabolic regulation.  Myc and myb 
are targets of cell cycle regulatory proteins such as CDK1.  Thus the regulation of myc 
and myb ties nucleolin and ribosome biogenesis into growth regulation (Belenguer et al., 
1989; Greasley et al., 2000; Ying et al., 2000).  
Transcription of mammalian ribosomal DNA genes yields a 47S primary 
transcript, (~13,000 nt in humans), which is fully transcribed before any processing 
cleavage occurs (Steitz and Tycowski, 1995; Grummt, 1999).   Processing of the 47S 
primary transcript yields three mature ribosomal RNAs (18S, 5.8S, and 28S).  Coordinate 
expression of the three mature rRNAs is accomplished by their existing in a single 
transcript allowing 1:1:1 ratios of the mature rRNAs to be produced.  The 5S rRNA is 
transcribed by RNA polymerase III outside the nucleolus.  The expression of 5S rRNA is 
coordinated with the expression of the other ribosomal rRNAs; however, it is usually 
present in excess within the cell as compared to the other rRNAs.  This is probably to 
prevent production of the 5S rRNA being the limiting factor in ribosome biogenesis 
(Hadjiolov, 1985).  
The pre-rRNA maturation pathway varies among eukaryotic species as well as 
with growth and development in the same species.  The processing pathway in mouse 
cells is “typical” for other vertebrate processing pathways, and it has been well studied 
using in vitro processing lysates.  In the following description, “cleavage” refers to a 
particular site, but it has not been definitely established in many cases whether the 
“cleavage” is due directly to an endonucleolytic cleavage or whether the cleavage 
actually results from the trimming action of an exonuclease that initiated its attack from 
some other endonucleolytic site (reviewed by Eichler and Craig, 1994).    
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The initial pre-rRNA transcript is 47S.  It is rapidly cleaved in the 5′ external 
transcribed spacer (ETS) (+650 upstream of the 18S rRNA in mouse, +414 in humans).  
This initial event is known as the primary processing cleavage (Kass and Sollner-Webb, 
1987; Kass and Sollner-Webb, 1990; Kass et al., 1990; Craig et al., 1991).  Following 
this initial ETS cleavage (or coordinate with it), the 3′ end of the 28S rRNA is cleaved to 
yield the 45S intermediate.  The next cleavage occurs at the ETS-18S boundary yielding 
the 24S ETS RNA which is rapidly degraded, and the 41S downstream intermediate.  
Cleavage within the 41S pre-rRNA at the 18S-ITS1 boundary yields the mature 18S 
rRNA and a 36S intermediate.  The 36S intermediate in turn is cleaved at its ITS1-5.8S 
boundary releasing ITS1 to be degraded, and a 32S intermediate.  The 32S intermediate 
contains the 5.8S-ITS2-28S rRNA; it is cleaved at the ITS2-28S boundary to yield mature 
28S rRNA and a 12S intermediate.  This last processing event is well conserved, and it 
appears to be the only pathway for processing the 32S intermediate.  Finally, the 
remaining 12S intermediate is cleaved at the ITS2-5.8S boundary to yield the mature 
5.8S rRNA.  The 5.8S and 28S rRNAs are hybridized over a portion of their single 
stranded regions before processing cleavages are completed, and this relationship is 
maintained in the mature 60S (large) ribosomal particle.  The 5S rRNA, synthesized 
outside the nucleolus, requires very little processing as the primary transcript contains 
only a few extra nucleotides at its 3′-end.  The 5S rRNA either diffuses or is carried to the 
nucleolus by the La autoantigen (Wolin and Matera, 1999).   
Some RNA processing events, such as those involved in mRNA splicing, must be 
extremely precise to maintain the proper codon reading frame. It is not clear, however, if 
rRNA processing requires the same level of precision, since there is no reading frame to 
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maintain.  Limited heterogeneity of a few nucleotides has been reported for the ends of 
5.8S and 28S rRNAs in functioning ribosomes. Cleavages and trimming reactions may 
not be exact, but rather only approximate (Bowman et al., 1983; Eichler and Craig, 
1994).  
Ribosomal and non-ribosomal proteins associate with the primary transcript 
before transcription is completed.  Thirty nanometer structures known as terminal balls 
are clearly visible on growing primary transcripts in Miller spreads of actively transcribed 
rDNA (Mougey et al., 1993).  These terminal balls form on the ETS and are intimately 
involved in the initial cleavage that occurs in the ETS.  Processing is concurrent with 
assembly of the pre-ribosomal particle.  Ribosomal RNA intermediates do not exist as 
free RNA, but instead as ribonucleoprotein complexes. The 5.8S, 28S and 5S rRNAs 
associate with approximately 49 large-subunit ribosomal proteins that together form the 
large 60S ribosomal particle.  The 18S rRNA and approximately 33 small-subunit 
ribosomal proteins form the small 40S ribosomal particle (see Fig. 1.1).  Mature 
ribosomal subunits are exported to the cytoplasm by specific nucleoplasmic receptors and 
some members of the karyopherin family in an energy dependent process (Bataille et al., 
1990; Aitchison and Rout, 2000).  
In yeast, the processing scheme is basically similar to that just described for 
mammals, except that the primary transcript is a 35S pre-rRNA, and the 28S mature 
rRNA normally found in metazoans is only 25S in yeast.     Because the rate of pre-rRNA 
processing is more rapid in yeast than in mammals, cleavages at the 5′ ETS-18S and 
ITS1-5.8S boundaries appear to occur simultaneously.  Therefore, alternative pathways 
are not detectable under normal growth conditions in wild type yeast cells.  There are also 
 14 
fewer ribose methylations and psudeouridines present in mature yeast rRNA (Eichler and 
Craig, 1994; Filipowicz et al., 1999).  Other processing events also occur in certain 
organisms. For example, in Tetrahymena, there is a group I intron present within the 27S 
rRNA sequence that is spliced out during processing.  Some organisms including 
Drosophilia, Sciara, Euglena, some annelids, as well as mollusks remove small segments 
known as hidden breaks (roughly 19 nucleotides long) from their 28S rRNA during 
processing (Eichler and Craig, 1994).  
The initial cleavage event within the 5' ETS terminal balls involves fibrillarin, 
nucleolin and the small nucleolar RNA, U3 (Kass et. al, 1990; Turley et al., 1993; Ginisty 
et al., 1998).  Other factors implicated in other ribosomal rRNA processing cleavages 
include snoRNPs U8, U13, U14, U17, U20, E2, E3, snR10*, snR13,  snR30*, RNase 
MRP, RNase PR1* and the proteins fibrillarin, Nop56, Gar1p*, NOP2*, and NOP3* 
(Bennett and Clayton, 1990; Karwan et al., 1991; Peculis and Steitz, 1993; Steitz and 
Tycowski, 1995; Cavaille et al., 1996;  Meier, 1996; Ochs et al., 1996). The * designates 
a yeast protein with no identified metazoan homolog.  The roles played and the 
mechanisms of action of these factors remain unclear.  Recently, yeast factors responsible 
for the endonucleolytic cleavages and exonucleolytic trimming reactions responsible for 
producing the mature rRNAs were found to exist as a large complex, called the exosome. 
The exosome in yeast contains at least 10 proteins (Rrp4p, Rrp41p, Rrp42p, Rrp43p, 
Rrp45p, Rrp46p, Mtr3p, Rrp44p/Dis3p, Rrp4p, Rrp40p), and it is required for maturation 
of the 18S, 5.8S and 25S rRNAs (Allmang et al., 1999; Zanchin and Goldfarb, 1999).  
The human homolog of the yeast exosome, PM-Sci 100, has been localized to nucleoli of 
HeLa cells (Fomproix and Hernandex-Verdun, 1999; Mitchell and Tollervey, 2000; 
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Brouwer et al., 2001).  The mechanism directing cleavages is thought to involve primary 
sequences as well as the secondary structures of rRNA (Savino et al., 2001).  
Processing also includes a series of specific base modifications, namely ribose 2'-
O-methylation and pseudouridinine conversion (reviewed by Bachellerie et al., 1995; 
Maxwell and Fournier, 1995; Beven et al., 1996; Tollervey, 1996; Edward et al., 1997; 
Weinstein and Steitz, 1999).  The ribose 2'-O-methylation reactions are directed by the 
box C/D snoRNPs.  These RNPs contain small nucleolar RNAs that contain the 
conserved C box (RUGAUGA; where R is any purine) and D box (CUGA) elements near 
their 5' and 3' termini, respectively.  Internal C/D box sequences have also been identified 
(Box C' and D') (Kiss- László and Kiss  1996; Kiss- László and Kiss, 1998).  The box 
C/D snoRNAs contain small guide sequences that are complementary to the ribosomal 
RNAs.  These guide sequences form short duplexes within the rRNA (10-21 nt in length).  
Duplex formation allows the snRNAs to act as guides for the methylation machinery. The 
fifth residue upstream of the D box or D' box is methylated at the 2' position of the ribose 
ring (see Fig.1.2).  The proteins catalyzing the methylation reaction are not known, but 
both fibrillarin and p120 associate with box C/D snoRNAs, and both may have a S-
adenosyl methionine (SAM) binding site (Freeman et al., 1989; Koonin, 1994; Wang et 
al., 2000). 
The other class of snoRNAs, the box H/ACA RNAs, direct the psudeouridylation 
reaction.  The Box H/ACA snoRNAs have a conserved hairpin-hinge-hairpin-tail 
secondary structure that is required to direct psudeouridinine conversion.  Box H 
(ANANNA, where N is any nucleotide) is found within the hinge region, whereas box 
H/ACA lies 3 nucleotides from the 3' end of the guide RNA.  Box H/ACA snoRNAs base  
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Figure 1.2  The box H/ACA and box C/D snoRNAs.  A  The predicted structure of the 
hybrids between a box H/ACA snoRNA and the pre-rRNA at the sites of pseudouridine 
(Ψ) formation. The sequences flanking the site of modification are base-paired to the 
snoRNA in a complex pseudoknot structure, while the base that is to be modified by 
rotation about the N3-C6 axis is free to interact with the Ψ synthase. The base pairing 
involves two stretches of 3-10 nucleotides on either side of the base to be modified.  B  Ψ 
formation by base rotation.  C  The predicted structure of the hybrids between a box C/D 
snoRNA and the pre-rRNA.  The box C/D and/or C'/D'-pre-rRNA interaction generates a 
conserved structure with the box D or D' element placed five base pairs downstram from 
the site of 2'-O-methylation.  D  2'-O-methylation of the ribose sugar moiety. Used with 
permission Waggener 2001 
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pair with their target pre-RNA site to form two duplexes, forming a psudeouridylation 
pocket 14-17 nucleotides upstream of box H or ACA.  The unpaired uridine in the pocket 
is converted to psudeouridine (see Fig. 1.2) (Ganot et al., 1997; Ni et al., 1997; Bortolin 
et al., 1999).  The proteins dyskerin and Nopp140 are known to associate with box 
H/ACA snoRNAs (Mitchell et al., 1999).   
Although the functional significance of the post-transcriptional modifications are 
not fully understood, methylated and pseudouridylated residues are confined to the most 
highly conserved portions of the mature rRNA sequences found within the ribosome.  
These modified sites also correspond to the residues associated with the active site of the 
ribosome (Lewis and Tollervey, 2000).  An additional potential hydrogen bond at the N-1 
position is created by pseudouridine conversion, which may contribute to rRNA folding 
and contribute to overall stability in a manner similar to pseudouridine in tRNAs (Durant 
and Davis, 1999).  Ribose methylation may stabilize rRNA by increasing hydrophobic 
interaction surfaces (Smith and Steitz, 1997).  The physical interaction with snoRNAs 
themselves may alter the architecture of pre-rRNA and thus achieve proper folding of the 
mature rRNA molecule (Lewis and Tollervey, 2000).   
Processing and assembly of the pre-ribosomal particles involves ribosomal as well 
as non-ribosomal proteins.  From the moment that the pre-rRNA transcript comes off 
polymerase I, it associates with proteins (see above).  Non-ribosomal nucleolar proteins 
that localize in a ring around the FC-DFC boarder are thought to be some of the early 
associating proteins (Shah et al., 1996; Waggner and DiMario 2001).  They include 
Nopp140 and fibrillarin, which are implicated in pseudouridine synthesis and 2′-O-
methylation respectively, as well as a host of functions.  Conversely, B23 and nucleolin 
 18 
are localized throughout the DFC and partially into the GC.  B23 and nucleolin are 
believed to associate early in pre-rRNA processing, but then remain associated with the 
RNA until late assembly, perhaps playing a role in the vectorial movement of ribosomal 
particles through the nucleolus and the export of the completed ribosomal subunits to the 
cytoplasm, as well as a host of other possible functions (see below). 
Novel Nucleolar Functions 
In addition to its main role as the site of ribosome biogenesis, recent work 
suggests that the nucleolus is a major site of other RNA modifications, and that it plays 
roles in gene silencing, aging and cell cycle control (reviewed by Pederson, 1998b: 
Garcia and Pillus, 1999).  Certain small RNAs, destined to be components of 
ribonucleotide complexes, transiently associate with the nucleolus to undergo 
modification (see Fig 1.3).  For example, the signal recognition particle (SRP) RNA has 
been shown to transit through the nucleolus.  Experiments showed that fluorescently label 
SRP RNA, microinjected of into a mammalian cell nucleus, rapidly accumulated in the 
nucleolus before exiting to the cytoplasm.  Additionally, three of the six proteins found in 
the mature SRP particle have been localized to the nucleolus (Jacobson and Penderson, 
1998; Politz et al., 2000; Grosshans et al., 2001).  Telomerase RNA, a functional 
component of another ribonucleoprotein (telomerase), is also directed to the nucleolus via 
sequences on its 3' end.  The splicing small nuclear RNA, U6, localizes to the nucleolus 
where it undergoes 2'-O-ribose methylation (Tycowski et al., 1998; Lange and Gerbi, 
2000; Ganot et al., 1999).  The RNA component of human and yeast RNase P has also 
been localized to the nucleolus.  RNase P is involved in maturation of tRNAs.  Further, 












Figure 1.3  The RNA pathways within the nucleolus.  Adapted form Lewis and Tollervey 
(2000). 
 20 
only in tRNAs.  Interestingly, isopentenyl-6-adenosine synthetase is localized to the 
nucleolus, indicating that the nucleolus is the site of tRNA maturation (Pederson, 1998b).  
Thus the nucleolus may serve as a general center for the modification and processing for 
multiple gene transcripts other than ribosomal RNAs. 
NON-RIBOSOMAL NUCEOLAR PROTEINS 
 The nucleolar protein p120 (Nol1, NOP2*) was originally identified in human 
tumor cells by use of monoclonal antibodies (Witte et al., 1978).  Its abundance closely 
associates with cell proliferation, and it serves as a useful histological marker for tumor 
cell proliferation (Uchiyama et al., 1997).  Vertebrate p120 binds rRNA with a 
dissociation constant of 4 nM and is localized to the DFC which is consistent with a role 
in ribosome biogenesis (Gustafson et al., 1998).  Deletion of the yeast homolog, NOP2, 
leads to impaired processing of the 35S pre-rRNA; mature 25S and 5.8S rRNAs form, but 
not the 18S rRNA.  There is also a reduction in rRNA methylation (Hong et al., 1997).   
 Nopp140 (SRP40*, p130) was first cloned from rat using an assay looking for 
proteins that interacted with the nuclear localization signal (NLS) of the SV40 large T 
antigen (Meier and Blobel, 1990).  Nopp140 is a nucleolar phosphoprotein of 140 kDa, 
and it consists almost entirely of alternating acidic and basic domains.  The C-terminus is 
highly conserved compared to the rest of the protein with a 59% identity between rat and 
yeast.  Recently, a splice variant was identified in Drosophila melanogaster that 
contained a glycine and arginine rich carboxy domain instead of the evolutionary 
conserved carboxyl terminus (Waggner and DiMario, 2002).  Vertebrate Nopp140 
localizes to Cajal bodies and the DFC of the nucleolus, often in a ring around the FC.  
This staining pattern may reflect its interaction with RPA194 (the largest subunit of RNA 
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polymerase I) (Miau et al. 1997).  Similar to several other nucleolar proteins, Nopp140 
has both CKII and CDK1 recognition motifs, and it is highly phosphoylated during 
interphase (CKII) and mitosis (CDKI).  Like other nucleolar proteins, Nopp140 shuttles 
between the nucleus and cytoplasm (Meier and Blobel, 1992).  Shuttling is faster for 
Nopp140 than other nucleolar proteins, and Nopp140 appears to travel along tracks in the 
nucleus as determined by electron microscopy.  This, together with the ability of 
Nopp140 to bind nuclear localization signals, suggests a possible a role in the transport of 
nucleolar components (Meier and Blobel, 1992).  Nopp140 is a component of both box 
C/D and box H/ACA snoRNPs, and it may have a role in transport of snoRNPs to the 
nucleolus (Yang et al., 2000).     
 Identified by its reaction with autoimmune antisera, fibrillarin (NOP1*, B36) is a 
34 kDa nucleolar protein rich in asymmetric NG,NG dimethylarginine (aDMA) (Lischwe 
et al., 1985).   Fibrillarin is a conserved non-ribosomal nucleolar protein with clear 
homologues from yeast to humans (Aris and Blobel, 1991; Tollervey et al., 1993).  
Human fibrillarin consists of a well defined amino terminal glycine arginine rich (GAR) 
domain, two central RNA binding domains (RBDs) and a carboxy domain that may form 
alpha helices (Christensen and Fuxa, 1988; Aris and Blobel, 1991).  In the nucleolus, 
fibrillarin localizes to the DFC, often in a ring around the FC.  It is known to be involved 
in the primary pre-RNA processing reactions (cleavage and methylation) in vertebrates.  
Temperature sensitive mutations of NOP1 in yeast cause a decrease in methylation as 
well as impaired maturation of all rRNAs generated from the primary transcript at the 
non-permissive temperature. These processing defects may be indirectly related to its 
potential role in methylation.  Fibrillarin is known to be associated with all box C/D 
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snoRNAs, and it shares structural homology with an archean bacterial methyltransferase 
(Tollervey et al., 1993; Wang et al., 2000). 
 B23 (numatrin, NO38, nucleophosmin) is a multifunctional nucleolar protein, 
often referred to as a putative ribosome assembly factor.  It is present in both the DFC 
and GC (Ochs et al.1983; Biggiogera et al. 1991).  Its amino terminal end consists of 
repeating acidic and basic domains, similar to other nucleolar proteins (Nopp140 and 
nucleolin).  It can be phosphorylated by CKII, CDK1, and the CDK2/cyclin E 
heterodimer.   Although it lacks a consensus RBD, B23 can bind nucleic acids.  In doing 
so, B23 displays helix destabilizing properties and ribonuclease activities (Dumbar et al., 
1989; Herrera et al., 1995).  The nucleic acid binding properties are associated with its 
carboxyl terminus.  B23, however, is predominantly a hexamer in vivo, and the 
conditions that promote oligomerization in vitro abolish nucleic acid binding.  B23’s 
nucleic acid binding (apparent binding constant Kω = 50 nm) exhibits a very high 
coopertivity factor (ω) of 800, thus indicating that multimers may form on the DNA 
(Chan and Chan, 1995; Herrera et al. 1996; Wang et al., 1994; Dumbar 1989).  There are 
two expressed variants of B23 in humans.  The two forms are generated by alternative 
splicing of the mRNA; B23.1 is the major form, while B23.2 which lacks the last two 
exons, is localized primarily in the cytoplasm (Chang and Olson, 1989; Chang and Olson 
1990).  B23 has been identified as a myc-responsive gene due to myc-binding sequences 
in its first intron.  B23 can relieve transcriptional repression caused by the YY1 repressor, 
which was shown to specifically bind the promoter region of the B23 gene.  
Responsiveness to the myc transcription factor, the ability to relieve YY1 repression, and 
its ability to stimulate DNA polymerase α, together suggests a possible role in 
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transcriptional regulation (Takemura et al. 1994; Inouye and Seto, 1994; Chan et al.1997; 
Umekawa et al., 2001; Zeller et al., 2001).  B23 shuttles between the nucleolus and 
cytoplasm, and it has been implicated in the nucleolar localization of the viral Rev and 
Rex proteins via binding of their NLS signals.  B23 binds only SV40 type NLS 
sequences, and thus binding is enhanced by CKII phosphorylation of B23.  There is no 
apparent binding of B23 to bipartite NLS sequences (Fankhauser et al., 1991 Szebeni et 
al., 1995).   In a yeast two-hybrid assay, B23 was shown to interact with nucleolin (see 
below).  Taken together with its localization, nucleic acids binding properties, and 
ribonuclease activities, B23 is strongly implicated in ribosome biogenesis (Adachi et al., 
1993; Fankhauser et al., 1991; Li et al., 1996).  Finally, B23 has been shown to play an 
important role in regulation of centrosome duplication.  During mitosis, B23 redistributes 
to the spindle poles (centrosomes) via hyperphosphorylation, and it is released only upon 
dephosphorylation.  Phosphoylation of threonine 199 by CDK2/cyclin E in late G1 of the 
cell cycle causes dissociation of B23 from the spindle poles, which is critical for 
initiation of centrosome duplication (Okuda et al. 2000; Tokuyama et al., 2001).    
Nucleolin (C23, NSR1*, GAR2*) is a major nucleolar phosphoprotein that 
constitutes as much as 10% of the nucleolar protein in actively growing cells.  It has been 
implicated in rDNA transcription, rRNA processing, ribosome assembly and 
nucleocytoplasmic transport (Lapeyre et al., 1987; reviewed by Tuteja and Tuteja, 1998; 
Ginisty et al., 1999; Srivastava and Pollard, 1999).  The amino terminus consists of 
alternating acidic / basic domains (see Fig 1.4).  The basic domains contain CDK1 















Figure 1.4  A schematic diagram of Chinese hamster nucleolin as derived from the 
cDNA sequence of Lapeyre et al. (1987).  The amino-terminal one-third consists of 
alternating acidic (black boxes) and basic (open boxes) domains.  The carboxy-terminal 
two-thirds consists of four RNA-binding domains and the glycine and arginine rich 







phosphorylation sites (Belenguer et al., 1989; Peter et al., 1990; Li et al., 1996; Zhou et 
al., 1997) 
The function of the amino terminus remains unknown.  Nucleolin has been show 
to interact directly with snoRNA U3 to promote the primary processing reaction (Yang et 
al., 1994; Ginisty et al.1998; Ginisty et al., 2000). This interaction is mediated by the 
amino terminal third.  On the other hand, the acidic domains of acidic amino terminus 
have been proposed to bind histone H1 to perhaps displace H1 from the linker DNA 
causing chromatin decondensation.  The basic stretches within nucleolin contain an 
octapeptide repeat that bears strong similarity to histone H1, and those repeats could be 
responsible for nucleolin’s ability to modulate DNA condensation in chromatin (Olson 
and Thompson, 1983; Erard et al., 1988 Erard et al., 1990; Kharrat et al., 1991).   
Nucleolin has a bipartite nuclear localization signal (NLS) located between the 
amino terminal third and the four down-stream RNA binding domains (RBDs).  This 
NLS is necessary and sufficient for nuclear accumulation, but not nucleolar 
accumulation, which appears to be the result of interaction with rRNA (Schmidt-
Zachmann and Nigg, 1993; Créancier et al., 1993; Meβmer and Dreyer, 1993) (see 
below).  Down-stream of the NLS are the four consensus sequence RBDs that are 
responsible for nucleolin’s nucleic acid binding ability (see Fig.1.4).   Deletion analysis, 
however, shows that RBDs 1 and 2 are responsible for nucleolin’s high affinity sequence 
specific binding (Serin et al., 1997; Ginisty et al., 2001).  SELEX experiments identified 
a RNA sequence that nucleolin recognizes with high affinity, (Kd = 5 nm).  The RNA 
sequence consists of an 18 nt stem loop structure, with six nucleotides (UCCCGA) in the 
loop.  Sequence comparisons and mutagenesis allowed characterization of a nucleolin 
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binding site with a 5 nt stem and a 7-10 nt loop containing the motif (U/GCCCGA).  This 
constitutes the Nucleolin Recognition Element (NRE).  Sequences similar to NRE have 
been located in the 5' ETS of mouse pre-rRNA near the primary cleavage site.  This is 
consistent with nucleolin’s involvement with this cleavage (Ghisolfi et al., 1992a; 
Ghisolfi et al., 1992b; Ghisolfi-Nieto et al., 1996; Allain et al., 2000).   
Additionally, nucleolin can interact with G-G base paired rDNA that is able to 
form planar rings.  These unusual structures known as G quartets are stabilized by 
Hoogsteen bonding between the G’s.  Nucleolin binds these structures with very high 
affinity (Kd = 1 nM).  G quartets have not been observed in vivo, but they can form 
readily and stably in vitro.  No functional significance can be attributed to this nucleolin 
interaction, although it is the highest affinity interaction yet shown for nucleolin.  Runs of 
guanines capable of forming G quartets when single stranded are prevalent in rDNA.  
The rDNA exists in single-stranded form during replication or transcription and this 
might promote formation of these G quartets.  Nucleolin might modulate these G quartets 
if they exist.  This concept is consistent with nucleolin’s helicase activity (see below), 
highly specific binding, transcriptional regulation and nucleolar localization (Egyhazi et 
al., 1988; Tuteja et al., 1995; Hanakah et al., 1999).   
Near nucleolin’s carboxy terminus is a glycine arginine rich (GAR) domain 
defined by Arg-Gly-Gly (RGG) repeats interspersed with aromatic (particularly 
phenylalanine) residues (see Fig. 1.4).  Removal of this domain abolishes nucleolin’s 
non-specific (Kd ~ 100 nm) nucleic acid binding, as well as its nucleolar localization, 
presumably through loss of in vivo nucleic acid binding.  Schwab and Dreyer (1997) 
showed that RNase treatment induces the release of nucleolin from nucleoli in A6 cells, 
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thus supporting the idea that nucleolin localizes to nucleoli by binding pre-rRNA.  
Separately, the GAR domain by itself shows low affinity RNA binding (see below) (Kd ~ 
500 nm).  Strand annealing and limited ATP-dependent helix destabilizing (helicase) 
properties are attributed to the GAR domain, and they may be responsible for the GAR 
domain’s ability to modulate nucleolin’s interaction with RNA (Ghisolfi et al.,1992a; 
Heine et al., 1993, Hanakah et al.,1999; Hanakah et al., 2000), possibly by disrupting 
secondary structures of the RNA to thus allow access of the upstream RDBs. 
Nucleolin, like other nucleolar proteins, is known to shuttle between the nucleus 
and cytoplasm.  Nucleolin can also bind a subset of ribosomal proteins, thus implicating 
it in nucleocytoplasmic transport of these ribosomal proteins.  The interaction is only 
with a subset of ribosomal proteins, and is mediated by either nucleolin’s N-terminus or 
its GAR domain.  Several of these ribosomal proteins are known to be internally located 
in mature ribosomal subunits, thus indicating an early association of these ribosomal 
proteins with pre-rRNA.  Nucleolin has been shown to associate early with nascent pre-
rRNA (Herrera and Olson, 1986).  Knockouts of yeast nucleolin-like proteins, Gar2p 
from Schizosaccharomyces pombe and Nsr1p from Schizosaccharomyces cerevisiae, lead 
to accumulations of the 35S pre-rRNA, decreases in mature 18S rRNA, and an absence 
the of free 40S ribosomal subunit (Gulli et al., 1995; Kondo and Inouye, 1992).  Its early 
association with pre-rRNA, its location in the DFC (with some in the GC), and its 
specific binding of ribosomal proteins, all strongly implicate nucleolin in ribosome 
biogenesis.  Current thinking portrays nucleolin as a RNA chaperone, modifying or 
maintaining specific rRNA secondary structures to allow correct processing and/or 
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assembly of ribosomal proteins with the pre-rRNA (Beyer et al., 1977; Escande et al., 
1985; Borer et al., 1989; Bouvet et al., 1998).   
Nucleolin has also been implicated in a number of non-traditional roles for a 
nucleolar protein.  These include immunoglobulin gene switching, binding telomeric 
DNA, response to insulin, acting as a glucocorticoid receptor, a transcription factor for 
the ribosomal RNA genes, and even extracellular binding of an anti-HIV peptide at the 
cell surface (Csermely et al. 1993; Hanakahi et al., 1997; Nisole et al. 1999; Pollice et al., 
2000; Schulz et al., 2001).  The biological significance of these interactions is unknown, 
and they will have to await functional studies to discern their in vivo significance, if any.   
PROTEIN ARGININE METHYLATATION 
 Methylated derivatives of arginine were first identified over 30 years ago as 
radiolabeled acid hydrolysis products of in vitro incubations containing calf thymus 
nuclei and S-adenosyl-[14C-methyl]-L-methionine, as well as in studies looking for novel 
amino acids in urine (Paik and Kim, 1967; Paik and Kim, 1968; Kakimoto and Akazawa, 
1970).  Until very recently, the enzymes, their substrates, and the functional significance 
of this post-translational modification were enigmatic and largely unknown.  Very recent 
genetic and molecular biology approaches have rekindled interest in this modification by 
implicating it in processes from signaling and transcriptional activation to protein sorting 
(reviewed by Chiang et al., 1996; Kim et al., 1998; Gary and Clarke, 1998; McBride and 
Silver, 2001). 
 Three forms of methylarginine have been identified in eukaryotes: NG-
monomethlyarginine (MNA), NG,N'G (symmetric) dimethylarginine (sDMA) and NG,NG 
(asymmetric) dimethylarginine (aDMA).  All three modifications involve the guanido 
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nitrogens of the arginine side chain (see Fig. 1.5).  S-adenosyl-L-methionine 
(adomet/SAM) is thought to be the universal methyl donor for all enzyme catalyzed 
methylation events, including arginine methylation (Segal and Eichler, 1989; Chiang et 
al., 1996).  The methyl group from SAM can be transferred to oxygen, nitrogen, sulfur 
and carbon moieties.   A wide variety of both small biological molecules and larger 
macromolecules can be methylated.  They include DNA, RNA, lipids and proteins 
(Clarke, 1993). 
It appears that there are two distinct classes of protein arginine N-
methyltransferases, originally defined by substrate specificity.  Type I enzymes were 
originally found to be specific for the histone proteins, and these enzymes catalyze the 
formation of MNA and aDMA.  Type I enzymes were later found to methylate other 
proteins with a Km that is 100 fold better than for the histones.  These protein substrates 
include hnRNP A1, fibrillarin and nucleolin.  Type II enzymes were specific for myelin 
basic protein (MBP), and they catalyze the formation of MNA and sDMA.  For both 
enzymes, symmetric and asymmetric dimethylarginine derivatives pass through the 
monomethylated form, indicating a stepwise addition of methyl groups.  
Classification of Type I and II protein arginine methyltransferases is based on substrate 
specificity.  Type I enzymes cannot methylate MBP, but type II enzymes are capable of 
methylating Type I substrates, specifically hnRNP A1 and the histones, albeit with a 
lower Km than Type I enzymes.  Although the classification is somewhat confusing, Type 
I and II are generally associated with the final dimethylated product; that is, asymmetric 
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Figure 1.5  The stepwise synthesis of methylated arginine derivatives found in proteins. S-
adenosyl-L-methionine (SAM) serves as the methyl donor for two consecutive methylation 
events (indicated in ) on the guanidine nitrogens of arginine residues.  Type I 
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Purification of Type I enzymes met with variable results.  The enzymatic activity 
of the Type I enzyme is associated with a complex of 275 kDa. This complex is 
composed of 110 and 75 kDa polypeptides as judged by SDS-PAGE.  Several eukaryotic 
Type I protein arginine methyltransferases (PRMT) exist.  Six PRMT’s have been cloned 
in humans, while yeast appears to contain just one, called Hmt1/Rmt1 (Henry and Silver, 
1996; Tang et al., 1998).  None of the now characterized enzymes encoded by the cloned 
cDNAs are as large as the smallest polypeptides found in any of the previously purified 
complexes, raising confusion between early purification attempts and recent cloning 
results (Henry and Silver, 1996; Lin et al., 1996; Frankel and Clarke, 2000; Tang et al., 
2000; Frank et al., 2001; Rho et al., 2001).   
On the other hand, the Type II enzymatic activity is associated with a complex of 
about 500 kDa.  This complex is composed of two polypeptides with apparent molecular 
masses of 100 and 72 kDa.  One Type II protein arginine methyltransferase, 
PRMT5/JBP1, has been cloned with a molecular mass of about 45 kDa, again adding to 
the confusion between the components with a complex verses activity (Branscombe et al., 
2001; Gary and Clarke, 1998). 
    NG,NG dimethylarginine was found to be the major methylated derivative in rat 
liver nuclei.  Surprisingly, nuclear RNA binding proteins contain 65% of the aDMA in 
the cell (Boffa et al., 1977; Lin et al., 2000).  RNA binding proteins shown to contain 
aDMA, include: the yeast proteins Nsr1, Gar1, Gar2 Hrp1, Nop1, Nab2, Sbp1, Npl3, and 
the vertebrate proteins Ewing sarcoma protein (EWS), hnRNP A1, hnRNP A2, E1B-AP5, 
ICP27, Sam68, fibrillarin and nucleolin (Lischwe et al., 1981; Lischwe et al., 1982b; 
Lischwe et al., 1985; Najbauer et al., 1993; Rajpurohit et al., 1994; Liu and Dreyfuss, 
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1995; Mears and Rice, 1996; Siebel and Guthrie 1996; Frankel and Clarke, 1999; 
Valentini et al., 1999; Green et al., 2000; Lin et al., 2000; McBride et al., 2000; Nichols 
et al., 2000; Bedford et al., 2000; Belyanskaya et al., 2001; Kzhyshkowska et al., 2001). 
Almost all the proteins that contain asymmetrically dimethylated arginine have GAR 
domains (see above), and the methylated residues are restricted to these domains.  
Proteins that contain asymmetrically dimethylated arginine, but not classic GAR 
domains, are methylated at RXR or RG sequences, with the -1 position almost always a 
glycine residue (Lischwe et al., 1981; Kim et al., 1997; Hyun et al., 2000; McBride and 
Silver, 2001).  Methylation of arginine has little affect on the charge, or the length and 
direction of the electric dipole of the guanidinium group.  There are, however, subtle 
changes in the pKa of the side chain.  The addition of methyl groups increases local 
hydrophobicity and steric hindrance.  Perhaps the most important effect of methylation is 
the change in hydrogen bonding potential of the arginine side chain due to the removal of 
amino hydrogens (Raman et al., 2001).   
 Only recently have we gained a glimpse into the functional significance of 
arginine methylation.  Since arginine methylation is often found in nucleic acid binding 
proteins, in a domain known to be involved in nucleic acid interactions, it was only 
logical to examine potential role of protein methylation in nucleic acid binding.  
However, very limited work has been done in examining this question.  The RNA 
binding of hnRNP A1 to homopolymeric RNA was slightly decreased by methylation, 
but methylation has no effect on another RNA binding protein, Hrp1.  Therefore, the 
effect of methylation on the ability of a protein to bind RNA remains uncertain 
(Rajpurohit et al., 1994; Valentini et al., 1999). 
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The first protein arginine methyltransferase (Hmt1) was cloned by 
complementation of a synthetically lethal, defective NPL3 allele.  NPL3 normally 
encodes a protein involved in poly(A)+ RNA export (Henry and Silver, 1996).  
Methylation of Npl3 and another shuttling hnRNP protein, Hrp1, facilitated their export 
out of the nucleus, thus implicating methylation in the export of mRNA binding proteins.  
However, another hnRNP shuttling protein, Hrb1, was not affected by methylation (Shen 
et al., 1998).  Therefore, protein methylation might be involved in modulating protein-
RNA interactions between mRNA export proteins and their target mRNAs. 
Recent studies also implicate methylation in modulating protein-protein 
interactions.  For example, Sam68, a protein thought to act as an adaptor in signaling 
pathways and a substrate for Src kinase, normally interacts with both WW and SH3 
domain-containing proteins. Sam68 shows reduced binding to SH3 proteins when 
asymmetrically dimethylated, but no change in binding WW domain proteins (Bedford et 
al., 2000).  Similarly, when asymmetrically dimethylated Stat1 (signal transducer and 
activator of transcription) exhibits decreased affinity for its inhibitor, PIAS1 (Mowen et 
al., 2001).  In contrast, splicing factors SmD1 and SmD3 increase binding to the SMN 
(survival of motor neuron) protein by 16 fold when symmetrically dimethylated (Brahms 
et al., 2000; Friesen et al., 2001).  All of the above proteins (Sam68, Stat1, SmD1 and 
SmD3) bind nucleic acids, and arginine methylation appears to affect their binding to 
protein partners in a nucleic acid independent manners. 
Histones were among the first proteins identified as substrates for partially 
purified Type I protein arginine methyltransferases (Paik and Kim, 1968).  Although they 
contain aDMA, histones are very poor substrates compared to GAR domain containing 
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proteins, like hnRNP A1, nucleolin and fibrillarin.  Methylation of both lysine and 
arginine in histone tails appears to play roles in epigenetic control of gene expression 
through involvement in chromatin remodeling (Jenuwein and Allis, 2001).  Coactivator -
associated arginine methyltransferase 1 / protein arginine methyltransferase 4 
(CARM1/PRMT4) was the first identified protein arginine methyltransferase targeted to 
histones.  CARM1 is a transcriptional co-activator of hormone-induced gene activation in 
rats.  The ability to enhance transcription is mediated through the family of p160 
coactivators (SRC-1, GRIP1/TIF2, pCIP/RAC3/ACTR/AIB1/TRAM2), specifically by 
way of its interaction with GRIP1 (Chen et al., 1999).  Xu et al. (2001) demonstrated that 
nuclear hormone-dependent transcriptional activation by CARM1 is via methylation of 
arginines in histone H3 and CBP/p300 (CREB binding protein).  Additionally, CARM1 
also acts as a transcriptional repressor of cyclic AMP transcriptional activation mediated 
by cyclic AMP response element binding protein (CREB).  Methylation of specific 
arginine residues, R580 in p300, and R600 in CBP, block binding to CREB.  The 
methylated arginine found in the KIX domain of CBP/p300 is not in a known methylation 
motif.   
GAR DOMAINS 
GAR domains are characterized by the tripeptide motif, RGG.  Circular dichroism 
studies revealed the structure of the GAR domain as an extended β-spiral (Ghisolfi et al., 
1992b).  The RGG motif is repeated several times within the domain, and the motifs are 
usually clustered together, interspersed occasionally with an aromatic amino acid such as 
phenylalanine (see Fig. 1.4).  A GAR domain is frequently found in RNA binding 
proteins including, Gar1, Gar2, Nop1, Nop3, Nab2, Sbp1,  Npl3, NopA64, human DNA 
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helicase II, Ewing sarcoma protein, hnRNP A1, hnRNP A2, and fibrillarin (Russell and 
Tollervey, 1992; Tollervey et al., 1993; Gulli et al., 1995; de Carcer et al., 1997; Zhang 
and Grosse,1997; Frankel and Clarke, 1999; Nichols et al., 2000; Belyanskaya et al., 
2001; Green et al., 2002).  The GAR domain has been described as a RNA-binding 
domain, and it does independently exhibit non-specific, low affinity binding to RNA (Kd 
~ 500 nm) (Ghisolfi et al., 1992a).  Recently, nucleolin’s GAR domain was shown to 
bind G quartets with much higher affinity (Kd = 40 nm) (Hanakah et al., 1999).  Both 
stand annealing and helix destabilizing properties have been attributed to the GAR 
domain, and these activities may be responsible for the GAR domain’s ability to 
modulate RNA binding by the upstream RBDs in nucleolin (Pontius and Berg, 1990; 
Kumar and Wilson, 1990; Nadler et al., 1992; Ghisolfi et al., 1992b; Portman and 
Dreyfuss, 1994; Hanakah et al., 2000).  The GAR domain of hnRNP A1 is required for 
cooperative binding to RNA, but it is also required for interactions with other pre-mRNA 
binding proteins.  Nucleolin’s GAR domain shows a specific interaction with ribosomal 
protein L3, thus strengthening a possible role in protein-protein interactions and perhaps 
assembly of ribosomal proteins into ribosomes (Cobianchi et al., 1988; Cartegni et 
al.,1996; Bouvet et al., 1998).  The precise functions of nucleolin’s GAR domain remain 
unknown.   
This dissertation confirms pervious work by others showing that the GAR domain 
of Chinese hamster nucleolin is required for in vivo localization to interphase nucleoli. 
Examination of in vivo protein-protein interactions with other non-ribosomal nucleolar 
proteins used transiently expressed ∆GAR as a novel in vivo system.  Nopp140 did not 
redistribute in the presence of nucleoplasmic ∆GAR, indicating the Nopp140 and the 
 36 
amino terminal portion of nucleolin do not interact in vivo.  Fibrillarin did exhibit a slight 
increase in its nucleoplasmic signal indicating a possible interaction with ∆GAR 
nucleolin.  Transient expression of ∆GAR did strongly increase in the nucleoplasmic 
signal of B23, indicating an interaction with the amino terminal portion of nucleolin and 
B23. 
The objective of this dissertation is to examine the functional associations of the 
nucleolar protein nucleolin as a window into defining its role in the nucleolus.  
Additionally, we hope to define a role for the post-translational methylation of the GAR 
domain of nucleolin, and therefore perhaps provide a model for the methylation of other 
GAR domain containing RNA-binding proteins. 
This dissertation also shows that methylation inhibitors cause nucleolin to 
redistribute from its normal nucleolar localization, suggesting that methylation is a 
modulator of macromolecular interactions that are necessary for nucleolin’s proper 
nucleolar localization.  The arginines in the glycine arginine rich region of hamster 
nucleolin were substituted with lysine.  The mutant protein was shown not to be a 
substrate for a protein arginine methyltransferase with broad substrate specificity.  This 
dissertation demonstrates that nucleolin methylation is not required for its proper 









 Ribosomes are incredibly complex macromolecular assemblies.  They are 
responsible for translating the information stored in our nucleic acids into proteins that 
then give us form, respond to stimuli, catalyze our reactions, function in transport, 
provide immunity, regulate gene expression, and ultimately define our existence.  For 
these reasons, ribosomes form a crux of the cell, and therefore a central point of control.  
Regulation of their existence is of critical importance to the cell; degradation of 
ribosomes is a steady process related to the age of the ribosome.  Therefore, control over 
ribosome biogenesis must be exerted at the level of their production, and this occurs in 
the nucleolus.  The importance of the nucleolus as a fulcrum of cell regulation is borne 
out by the number of nucleolar targets affected by central regulators, such as cyclin 
dependent kinase 1 (CDK1), cyclin dependent kinase 2 (CDK2), retinoblastoma protein 
(Rb), p53, casein kinase II (CKII), my,c and CREB binding protein (CBP), all of which 
have multiple nucleolar targets (Pederson, 1998a; Glover, 1998; Srivastava and 
Pollard,1999; Visintin and Amon, 2000; Leary and Huang 2001; Morris and Dyson, 
2001; Chan and La Thangue, 2001; Cadwell and Zambetti, 2001; Nigg, 2001).  These 
targets include chromatin remodeling factors, RNA polymerase I transcription factors, 
and rRNA processing and assembly factors.  For these reasons, understanding ribosome 
biogenesis is of great importance in generating an integrated view of cellular control. 
 Great effort has been focused on elucidating the mechanisms of ribosome 
biogenesis, the organization of the ribosomal genes and their transcriptional control, as 
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well as post-translational modification of the pre-rRNA.  Several non-ribosomal 
nucleolar proteins and small nucleolar RNAs (snoRNAs) are known to be involved in 
pre-rRNA processing and ribosome assembly.  However, the exact functions of the 
nucleolar proteins remain poorly understood.  Pinning down the exact function of these 
factors has been hampered because ribosome biogenesis is currently impossible to 
reconstitute in vitro due to its complexity.  Although lower eukaryotes are amenable to 
genetic manipulation, the results from such genetic experiments are difficult to interpret 
because effects are often pleotropic with factors appearing to have multiple overlapping 
functions.  There are also very distinct differences between vertebrates and yeasts in 
regards to ribosome biogenesis (see below).   
For example, yeast nucleoli are very large compared to nucleoli in vertebrate 
cells.  Yeast nucleoli occupy almost one third of the nucleus, and in the case of 
Schizosaccharomyces cerevisiae, nucleoli do not disassemble during mitosis.  The 
nucleolar sub-compartments of yeast nucleoli are less distinct than the analogous sub-
compartments in nucleoli of higher eukaryotes.  In fact, until recent advances in 
cryofixation, these sub-compartments in yeast nucleoli were believed not to exist 
(Trumtel et al., 2000).   
Nucleolar factors involved in ribosome biogenesis vary in their conservation 
among eukaryotes.  For example, NOP1/fibrillarin is highly conserved, with 81% amino 
acid identity between yeast and vertebrate homologs.  Other nucleolar factors, however, 
like vertebrate nucleolin do not have true homologs in yeast.  Gar2p from 
Schizosaccharomyces pombe and Nsr1p from Schizosaccharomyces cerevisiae share only 
37% identity with vertebrate nucleolin in the most highly conserved domain, the carboxy 
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terminal GAR domain.  The overall amino acid identity between the full-length 
vertebrate nucleolin and either Gar2p or Nsr1p is much less than 37%.  The only real 
homology between the vertebrate nucleolins and those of yeast is the presence of similar 
domain structures.  In fact, both Gar2p and Nsr1p are considered structural “homologs” 
of vertebrate nucleolin, but not of each other.  Although, Gar1p and Nsr1p share 52% 
amino acid identity, they are not considered homologs due to distinct differences between 
their respective domain structures (Aris and Blobel 1991; Kondo and Inouye, 1992; Gulli 
et al., 1995).   There are also several yeast factors; Gar1p1, NOP3, NOP4, NOP5 and 
NOP77 for which there are no apparent vertebrate homologs (Russell and Tollervey, 
1992; Sun and Woolford, 1994; Berges et al., 1994; Bagni and Lapeyre, 1998: Wu et al., 
1998).  It appears, therefore, that although yeast is a convenient genetic system and a 
valuable organism that can teach us much about eukaryotic nucleoli, it is not directly 
applicable to the detailed understanding of vertebrate nucleoli.  In order to understand 
ribosome biogenesis in vertebrates, and how these nucleoli affect vertebrate growth, 
development, physiology and aging, we must be study vertebrate nucleoli. 
Abundant factors implicated in pre-ribosomal processing and/or assembly in 
vertebrates include Nopp140, fibrillarin, B23 and nucleolin. These nucleolar proteins 
often appear to have multiple functions.  Nucleolin for example, is believed to have roles 
in ribosomal gene transcription regulation, pre-rRNA folding and processing, import and 
assembly of ribosomal proteins, maintaining nucleolar structure, and perhaps even signal 
transduction. 
Nopp140 (nucleolar phosphoprotein of 140 kDa), consists almost entirely of 
alternating acidic and basic domains.  The C-terminus is highly conserved, with 59% 
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identity between rat and yeast.  The rest of the protein shows much less conservation.  
Nopp140 interacts with RPA194 (the largest subunit of RNA polymerase I), and 
Nopp140 is a component of box C/D and box H/ACA snoRNPs that are respectively 
involved in 2'-O-methylation and pseudouridine conversion (Miau et al. 1997; Yang et 
al., 2000).  Nopp140 localizes to Cajal bodies and in the DFCs of nucleoli, often in rings 
around the FCs.  This staining pattern may reflect its association with RNA polymerase I 
and early associating factors involved in the post-translational modification of pre-
ribosomal RNA.   Similar to several other nucleolar proteins, Nopp140 has both CKII and 
CDK1 recognition motifs, and it is highly phosphoylated during interphase and mitosis.   
Nopp140 shuttles between the nucleus and cytoplasm (Meier and Blobel, 1992).  
Shuttling is faster for Nopp140 than other nucleolar proteins, suggesting a possible a role 
in the transport of nucleolar components (Meier and Blobel, 1992). 
The co-localization of nucleolin and Nopp140 in the DFC of nucleoli certainly 
suggests the possibility for interaction between the two proteins.  The alternating acidic 
and basic domains of Nopp140 could possibly interact with the acidic and basic stretches 
of amino acids within the amino terminus of nucleolin through electrostatic forces.  
Nopp140 is known to associate with snoRNPs that interact with the pre-rRNA to act as 
guides for post-translation modifications.  Nucleolin is a tenacious nucleic acid binding 
protein and has high affinity binding sites in the 5'-ETS of the pre-rRNA primary 
transcript.   Nucleolin might interact with Nopp140 indirectly mediated by ribosomal 
rRNA.  However, to date no interactions between nucleolin and Nopp140 have been 
observed. 
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Fibrillarin is a 34 kDa conserved non-ribosomal nucleolar protein (Tollervey et 
al., 1993).  Fibrillarin consists of a well defined amino terminal GAR domain that is rich 
in aDMA.   Two central RNA binding domains (RBDs) follow the GAR domain.  Its 
carboxy domain may form alpha helices (Christensen and Fuxa, 1988; Aris and Blobel, 
1991; Lischwe et al., 1985).  Like Nopp140, fibrillarin localizes to the DFC, often in a 
ring surrounding the FC.  Fibrillarin is known to be involved in the primary pre-rRNA 
processing reactions (cleavage) in vertebrates.  Fibrillarin is also known to associate with 
box C/D snoRNAs (methylation) (Tollervey et al., 1993). 
Both fibrillarin and nucleolin bind pre-rRNA, localize to the DFC of nucleoli and 
associate with the U3 snoRNA that is involved in the primary cleavage event in the 5'-
ETS of pre-rRNA.  Possible interactions between the two proteins might be indirect 
through pre-rRNA or the U3 snoRNA.  The GAR domain ofpre-mRNA binding protein, 
hnRNP A1, was shown to self-associate, indicating that GAR domains might represent 
protein-protein interaction motifs (Cartegni et al., 1996).  It is possible that nucleolin and 
fibrillarin could interact though their respective GAR domains. 
B23 consists of repeating acidic and basic domains, and although it lacks a 
consensus RBD, B23 can bind nucleic acids.  B23 also displays other nucleic acid 
modulating properties, namely helix destabilization properties and ribonuclease activity 
(Dumbar et al., 1989; Herrera et al., 1995).  The nucleic acid binding properties are 
associated with its carboxyl terminus.  B23 is present in both the DFC and GC (Ochs et 
al.1983; Biggiogera et al. 1991).  Like nucleolin, B23 shuttles between the nucleolus and 
cytoplasm (Borer et al., 1989).  
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Both B23 and nucleolin are among the most abundant nucleolar proteins in 
actively growing cells, and they are strongly implicated in ribosome biogenesis.  Their 
co-localization in both the DFC and GC, in addition to their apparent central role in 
ribosome biogenesis, all suggest possible interactions between nucleolin and B23.  We 
already know that B23 interacts with nucleolin by yeast two-hybrid assay and immuno-
precipitation experiments (Li et al., 1996), but not as of yet in vertebrate cells. 
Previously the GAR domains of some vertebrate nucleolins (Xenopus, chicken, 
rat) were demonstrated to be required for nucleolar localization.  Nucleolin lacking this 
domain accumulated in the nucleolplasm (Heine et al., 1993; Meβmer and Dreyer, 1993; 
Schmidt-Zachmann and Nigg, 1993).  In this chapter, the previous results for ∆GAR 
nucleolin are confirmed for hamster nucleolin, and this abnormal localization is used to 
examine in vivo interactions between ∆GAR and the other nucleolar proteins, Nopp140, 
fibrillarin, and B23. 
Nucleolar proteins are dynamic, continuously cycling between the nucleolus and 
nucleoplasm (Phair and Mistili, 2000).  Nucleolar factors that normally interact with the 
amino terminal two-thirds of nucleolin in the nucleolus should therefore interact with 
∆GAR in the nucleoplasm, thereby increasing their nucleoplasmic presence.  By 
observing these interactions in non-disrupted living vertebrate cells, we hope to 
distinguish biologically relevant in vivo interactions of nucleolin from those that are not 
biologically relevant. 
Finally, nucleolar proteins are often implicated in diverse cellular functions 
because immuno-precipitations or similar assays suggest apparent interactions with other 
various cellular, nuclear and nucleolar protein components.  Generation of cell lysates for 
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immuno-precipitations, however, expose components to conditions that may not exist in 
vivo.  It is doubtful that all the interactions observed with nucleolin are biologically 
relevant, and teasing apart the important facts from the spurious interactions is crucial to 
understanding the roles of the nucleolar proteins, and therefore, ribosome biogenesis 
itself. 
MATERIALS AND METHODS 
 
Construction of Amino Terminal Myc-Tagged ∆GAR 
 
 The Chinese hamster nucleolin cDNA was kindly provided by Dr. Francois 
Amalric (Centre de Recherché de Biochimie et de Genetique Cellulaires du Centre 
National de la Recherché Scientifique, France).  The cDNA was ligated into the pSP64 
vector at the EcoR I and BamH I sites.  This construct is 5329 bp in length, and is named 
pSNH.  The cDNA encoding Chinese hamster nucleolin was removed from pSNH and 
cloned into myc-6-D (a derivative of pBluescript KS+ (Stratagene La Jolla, CA).  Myc-6-
D contains six tandem myc tags in the polylinker linker region; it was a gift from Dr. 
Mark Roth of the Fred Hutchinson Cancer Research Center, Seattle, WA.  One of the myc 
tags was removed by cutting myc-6-D with Nco I and EcoR I and ligating in the nucleolin 
cDNA, cut with the same restriction enzymes. In the resulting construct, nucleolin is 
behind and in frame with the DNA sequence encoding 5 tandem human myc-tags such 
that the nucleolin is tagged at its amino terminus.  This construct was created by YingJie 
Zhu in our lab, and she named it 21R CHO WT.  To generate the CHO ∆GAR construct, 
21R CHO WT was partially digested with Nco I followed by complete digestion with 
EcoR I.  A 5130 bp fragment corresponding to the myc-tagged hamster nucleolin cDNA 
lacking base pairs 1969-2152 (encoding the GAR domain) was gel purified by phenol 
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and phenol / chloroform extraction.  The 5′ overhangs left by Nco I and EcoR I were 
filled in using the Klenow fragment of E. coli DNA polymerase I (New England Biolabs, 
Beverly, MA) to generate blunt ends.  The filled-in Nco I and EcoR I sites were then 
ligated together using T4 DNA ligase (New England Biolabs, Beverly, MA) to generate 
CHO ∆GAR.  The truncated nucleolin cDNA was subsequently ligated into the 
eukaryotic expression vector, pBK-CMV (Stratgene, La Jolla, CA) using Xho I and Xba I 
sites common to both polylinkers. This construct was named CHO pBK-CMV ∆GAR.   
Myc-tagged wild type nucleolin was previously cloned into the pBK-CVM vector 
in our lab by Dongrai Lu, and this construct was named pMCN.  Both pMCN and CHO 
pBK-CMV ∆GAR plasmid DNAs were double CsCl-purified according to Manatis et al. 
(1982).  The ultra pure pMCN and CHO pBK-CMV ∆GAR DNA were used to 
transiently transfect cultured HeLa cells. 
Transient Transfection of HeLa Cells with ∆GAR Nucleolin 
 HeLa cells were purchased from the School of Veterinary Medicine (Louisiana 
State University) and grown in DMEM (Debecco’s Modified Eagles Medium) 
supplemented with 10% heat-inactivated fetal calf serum (Hyclone, Logon, UT) and 50 
µg/ml gentamycin (Life Technologies GibcoBRL Gaithersburg, MD) at 37°C in a 5% 
CO2 incubator.  Actively growing cells were allowed to reach 80-90% confluence in a 75 
cm2 cantered flask before being harvested using 0.25% trypsin (School of Veterinary 
Medicine, Louisiana State University).  Cells were pelleted and resuspended in 5 mls of 
DMEM with 10% fetal calf serum.  Recovered cell densities were determined using a 
hemocytometer.  Coverslips were sterilized by flaming with 95% ethanol and placed in 
wells of a six well plate.  The volume needed to yield 1.6 X 105 cells per well was 
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calculated, and 3.5 mls DMEM with 10% fetal calf serum minus the volume calculated 
was added to the wells.  The calculated volume of cells was then added to the coverslips 
to bring the total volume of culture medium up to 3.5 mls per well.  Cells were then 
incubated for 24 hours at 37°C in 5% CO2, to allow them to adhere to the coverslips. 
Transient transfections were achieved via DNA-calcium phosphate precipitation using 
the N1N-bis (2-hydroxyethyl)-2- aminoethanesulfonic acid (BES) method of Chen and 
Okayama (1988).  The DNA was incubated with 0.25 M CaCl2 and 1 x BBS for 15-20 
minutes during which time a fine precipitate forms.  Ten micrograms of CsCl-purified 
DNA was added per well.  After addition of the DNA precipitate, cells were incubated at 
35°C in 3% CO2 for 12-18 hours to induce uptake of the DNA-calcium precipitate.  Cells 
were then washed twice with 1 x PBS (phosphate buffered saline) and placed in fresh 
DMEM with 10% fetal calf serum.  The cells were subsequently incubated for an 
additional 24 hours at 37°C in 5% CO2,.   Cells were then removed from the incubator 
washed twice in 1 x PBS and fixed for one hour in 2.5% paraformaldehyde in 0.5 x PBS.  
Cells were blocked with 10% horse serum for 1-24 hours before staining with mouse 
anti-myc mAb 9E10 hybridoma supernatant for one hour, followed by three washes with 
10% horse serum.  The cells were stained the flourescein-conjugated goat anti-mouse IgG 
(Pierce, Rockford, IL, USA) diluted 1/200 in 10% horse serum.   
Construction and Integration of C-terminally EGFP-tagged Chinese Hamster 
∆GAR Nucleolin 
 
 The GAR domain was deleted from nucleolin in pSNH using the internal Nco I 
site located at nucleotide +1886 and the EcoR I from the downstream polylinker region of 
the pSP64 vector.  The 5′ overhanging ends were filled-in using Taq DNA polymerase 
(Promega Corp., Madison, WI) at 72°C, for 20 minutes.  Two hundred units of T4 DNA 
 46 
ligase (New England Biolabs, Beverly MA) were used to blunt-end ligate the resulting 
ends of the plasmid to generate pSNH ∆GAR.  Sequence encoding nucleolin ∆GAR was 
cut out of pSNH ∆GAR using Xba I (upstream polylinker) and EcoR I (downstream 
polylinker).  The resulting 1886 bp fragment was gel purified and ligated into pEGFP-N3 
(Clontech LaJolla, CA) at the Xba I and EcoR I sites in the vector maintaining the 
reading frame with the carboxyl terminal EGFP peptide.  The same procedure was used 
to construct a plasmid that encodes full-length wild type hamster nucleolin from the 
pSNH vector.  The resulting vectors, named pEGFP-N3 CHO (∆GAR or WT) were 
sequenced at the Iowa State University DNA Sequencing and Synthesis Facility (Ames, 
IA) (http://www.dna.iastate.edu/) to confirm that the nucleolin cDNA was in frame with 
the sequences encoding EGFP peptide.  Ultra pure plasmid DNA, either pEGFP-N3 CHO 
∆GAR or pEGFP-N3 CHO WT DNA, was prepared via double CsCl gradient 
ultracentrigugation according to Manatis et al. (1982). 
Chinese hamster ovary (CHO) cells were purchased from the School of 
Veterinary Medicine (Louisiana State University) and grown to 80% confluency in 125 
mm2 sterile tissue culture petri dishes.  When growing the CHO cells, the DMEM was 
supplemented with 1 µM proline from a frozen sterile 100 µM stock.  CHO cells were 
transfected via DNA-calcium phosphate precipitation using the N1N-bis (2-hydroxyethyl) 
- 2 - aminoethanesulfonic acid (BES) method of Chen and Okayama (1988).  Twenty 
micrograms of CsCl-purified pEGFP-N3 CHO ∆GAR or pEGFP-N3 CHO WT DNA 
were incubated with 0.25 M CaCl2 and 1x BBS for 15-20 minutes.  After addition of the 
DNA precipitate to the cells, the cells were incubated at 35°C in 3% CO2 for 16 hours.  
The cells were then washed twice with 1 x PBS and placed in fresh DMEM with 10% 
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fetal calf serum and incubated for 48 hours at 37°C in 5% CO2 to allow strong expression 
of the neomycin resistance gene.  G418 (Life Technologies GibcoBRL, Gaithersburg, 
MD) was then added to the media to a final concentration of 1 µM after 48 hours.  The 
cells were allowed to grow under strong selection of G418 (1µM) until colonies 
appeared, usually between three to four weeks during which time the media was replaced 
every three days.   
To establish clonal purity, cells were treated with 0.25% trypsin to remove them 
from the petri dish, washed once in 1 x PBS and DMEM before determining cell 
concentration using a hemocytometer.  Cells were then diluted with DMEM to a 
concentration of 15 cells / ml and 20 µl of this dilution was added to each well of a 96 
well plate.  Each well already contained 300 µl of DMEM with 10% fetal calf serum and 
1 µM G418.  This dilution and plating should yield an average of one cell every three 
wells.  Culture medium was replaced every four days for the first two weeks.  Wells 
containing a single visible colony were scraped with a 1 ml pipette to detach some of the 
cells that were then placed in a six well plate containing ethanol-sterilized coverslips and 
3 mls of DMEM with 10% fetal calf serum and 1 µM G418.  Cells were incubated for up 
to four days, washed twice in 1 x PBS, and fixed in 2.5% paraformaldehyde in 0.5 x PBS 
for one hour.  The cells were visualized by flouresence microscopy to determine which 
colony displayed consistent high-level expression of EGFP-tagged nucleolin.  Those cells 
were then collected form either the original 96 well plate and/or the 6 well subculture 
plate via scraping.  These cells were placed in a 75 cm2 tissue culture flask with DMEM 
with 10% FCS and grown to 80% confluency in the presence of G418 before using them 
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in an experiment or freezing them in liquid nitrogen.  The freezing medium consisted of 
90% fetal calf serum and 10% DMSO. 
Potential In Vivo Protein-Protein Interactions of Nucleolin with Other Nucleolar 
Proteins 
  
CHO cells that stably expressed C-terminal EGFP-tagged wild type or ∆GAR 
nucleolin were stained with antibodies directed at other nucleolar proteins to determine if 
the nucleoplasmic ∆GAR could increase the nucleoplasmic signal of these other 
nucleolar proteins.  Cells that stably expressed C-terminal EGFP-tagged wild type or 
∆GAR nucleolin were harvested using 0.25% trypsin, pelleted and resuspended in 
DMEM with 10% fetal calf serum.  Recovered cell densities were determined using a 
hemocytometer.  Coverslips were sterilized by flaming with 95% ethanol and placed in a 
six well plate.  The volume needed to yield 1.6 X 105 cells per well was calculated and 
3.5 mls DMEM with 10% fetal calf serum minus the volume calculated was added to the 
wells.  The calculated volume of cells was then added to the coverslips to bring the total 
volume of DMEM with 10% fetal calf serum up to 3.5 mls per well.  Cells were 
incubated for 24 hours at 37°C in 5% CO2 to allow them to adhere to the coverslips.  
Attached cells were washed twice in 1 x PBS and fixed in 2.5% paraformaldehyde in 0.5 
x PBS for one hour, prior to being permeabalized with 0.5% Triton X-100 in 1 x PBS for 
five minutes.  Cellular proteins were then blocked with 10% horse serum for 1-3 hours 
before staining with primary antibody.  The primary antibodies were mAb 72B9 directed 
against fibrillarin (Reimer et al., 1987)  (1/100), anti-B23 antibodies courtesy of Dr. Ben 
Valdez directed against B23 (1/400), and mAb RH10 courtesy of Dr. Tom Meier directed 
against Nopp140 (1/100).  Cells were washed and then reblocked with 10% horse serum 
prior to staining with the appropriate secondary antibody that was coupled to rhodamine.  
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Standard phase contrast and immuno-flourescence microscopy was preformed using a 
Ziess Axioskop using a 40x phase contrast/neoflour objective.  Pictures were taken with 
Fuji Etkachrome 400 speed color slide film or Kodak T-Max 400 speed black and white 
film.   
RESULTS 
Expression of myc-tagged Chinese hamster nucleolin lacking its GAR domain 
(∆GAR) via transient transfection in HeLa cells demonstrated that the GAR domain of 
hamster nucleolin was required for in vivo localization to interphase nucleoli.  Nucleolin 
lacking its GAR domain failed to localize to interphase nucleoli, but instead exhibited 
uniform staining of the nucleoplasm (see Fig. 2.1, C and D).  This was not the case for 
the wild type myc-tagged full-length nucleolin (see Fig. 2.1, A and B).  The results also 
indicate that the amino terminal myc-tag tag did not interfere with nucleolar localization. 
For convenience, the enhanced green flourescent protein (EGFP) was fused to the 
carboxyl terminus of Chinese hamster nucleolin lacking its GAR domain by ligating the 
truncated nucleolin cDNA into the eukaryotic expression vector, pEGFP-N3, behind the 
strong CMV promoter.  A similar construct with wild type CHO nucleolin was created to 
act as a control in subsequent experiments.  The plasmids containing the fusion proteins 
were transfected into CHO cells and selected for stable intergration using G418.  High 
level expression could be obtained initially for both the wild type and GAR truncated 
fusion proteins (see Fig 2.2).  However, there was a continuous loss of expressing cells 
over time even under continued selection.  The loss of expression was particularly acute 
for the ∆GAR nucleolin fusion protein with roughly 30% reduction in the number of 
expressing cells after each passage of a 25 cm2 flask.  After four passages in the presence 
Figure 2.1 A B
C D
HeLa cells transfected with wild type -tagged nucleolin (panels and ) or
-tagged nucleolin lacking the GAR domain ( GAR) (panels and ). Cells were stained
with the monoclonal antibody 9E10 followed by goat anti-mouse flourescein-conjugated









Figure 2.2 CHO cells stably expressing GFP-tagged wild type and GAR nucleolin. Cells
pictured after a total of three weeks. Panels A and B show CHO cells
stably expressing wild type nucleolin that is C-terminally tagged with EGFP. Panels C and D
show CHO cells stably expressing GAR nucleolin that is C-terminally tagged with EGFP.
Calibration bar is 20 m for all panels.




of continued selection (approximately four weeks), there was complete loss of cells 
expressing the ∆GAR fusion protein.   
The wild type nucleolin-EGFP fusion protein faired much better with only a 10-
15% decrease in the number of cells expressing the fusion protein after each passage in a 
25 cm2 flask.  Some cells continued to express the wild type fusion protein after four 
months of culture (~12 passages).   
The expression of the fusion proteins slightly altered the morphology of the 
nucleoli in the CHO cells.  Nucleoli in cells expressing the full-length version of 
nucleolin were larger than untransfected controls (see Figs. 2.2, 2.3, 2.4, A and C).  This 
result is consistent with the finding of Zhu et al. (1999) who showed that over-expression 
of nucleolin in CHO cells caused enlarged DFCs.  The nucleoli in cells expressing 
nucleolin lacking its GAR domain were occasionally slightly smaller than nucleoli in 
control cells (see Fig. 2.2D and C), suggesting some loss of nucleolar material, perhaps to 
the nucleoplasm due to an interaction with the nucleoplasmic-localized ∆GAR nucleolin 
(see below).  
The EGFP-tagged ∆GAR nucleolin does not localize to interphase nucleoli. 
Instead, it is evenly distributed throughout the nucleoplasm.  Since nucleolar proteins are 
dynamic, continuously cycling between the nucleolus and nucleoplasm, this would 
potentially allow other nucleolar proteins that normally interact with the amino terminal 
two-thirds of nucleolin in the nucleolus to interact with ∆GAR in the nucleoplasm.  Such 
a dynamic shuttling and interaction with nucleolin would increase their respective 
nucleoplasmic signals (Phair and Mistili, 2000).  Antibodies to three abundant nucleolar  
Figure 2.3 Localization of endogenous Nopp140 in Chinese hamster ovary cells. Panels A-C
are untransfected CHO cells as a control of anti-Nopp140 antibody staining. Panels D-F are
CHO cells stably expressing EGFP-tagged wild type nucleolin showing co-localization of
EGFP-nucleolin and endogenous Nopp140. Panels G-H are CHO cells stably expressing EGFP-
tagged GAR nucleolin, with no increase in the nucleoplasmic signal of Nopp140 due to GAR
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Figure 2.4 Localization of endogenous fibrillarin in Chinese hamster ovary cells. Panels A-C
show untransfected CHO cells as a control of anti-fibrillarin staining. Panels D-F show CHO
cells stably expressing EGFP-tagged wild type nucleolin that co-localizes with endogenous
fibrillarin. Panels G-H show CHO cells stably expressing EGFP-tagged GAR nucleolin, with
a slight increase in the nucleoplasmic signal of fibrillarin due to GAR nucleolin. Calibration







proteins (Nopp140, fibrillarin and B23) were used as probes to examine their localization 
in the presence of wild type or ∆GAR EGFP-tagged nucleolin in transfected CHO cells. 
Endogenous Nopp140 localizes to nucleoli in untransfected CHO cells (see Fig. 
2.3, A and C).  This localization is undisturbed in the presence of EGFP-tagged wild type 
nucleolin (see Fig. 2.3, D-F).  In panel F of Figure 2.3, the arrow indicates Nopp140 
localizing to a Cajal body, indicating that expression of the EGFP-tagged construct does 
not interfere with the behavior or localization of Nopp140.  In cells expressing ∆GAR 
nucleolin, Nopp140 is unaffected in its intra-nuclear distribution, exhibiting no increase 
in its nucleolplasmic signal.  These normal localizations suggest no direct or indirect 
interaction with the amino terminal two thirds of nucleolin and endogenous Nopp140. 
Endogenous fibrillarin localizes to nucleoli in untransfected CHO cells (see Fig. 
2.4, A and C).  In the presence of ∆GAR nucleolin, the amount of fibrillarin in the 
nucleoplasm, as detected by indirect immunostaining, appeared to increase slightly (see 
Fig. 2.4, H and I), possibly indicating a weak or indirect interaction with the amino 
terminal two-thirds of nucleolin.  However, this result was somewhat variable from cell 
to cell.  The expression of EGFP-tagged full-length nucleolin did not alter the staining 
pattern of endogenous fibrillarin (see Fig 2.4, E and F), thus indicating that the increased 
nucleoplasmic signal in the presence of ∆GAR is not simply due to the over expression of 
the ∆GAR EGFP-tagged construct. 
Endogenous B23 localizes to nucleoli in untransfected CHO cells (see Fig. 2.5, A 
and C).  In the presence of exogenously expressed EGFP ∆GAR nucleolin, however, 
there was a dramatic increase in B23 in the nucleoplasm as indicated by indirect- 
Figure 2.5 Localization of endogenous B23 in the Chinese hamster ovary cells. Panels A-C are
untransfected CHO cells as a control of anti-B23 staining. Panels D-F are CHO cells stably
expressing EGFP-tagged wild type nucleolin showing co-localization of EGFP-nucleolin and
endogenous B23. Panels G-H are CHO cells stably expressing EGFP-tagged GAR nucleolin,
with a distinct increase in the nucleoplasmic signal of B23 due to GAR nucleolin. Calibration
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immunostaining (see Fig. 2.5, H and I).  Since B23 localizes normally to nucleoli in the 
presence of full-length EGFP-tagged nucleolin (see Fig. 2.5, E and F), the redistribution 
seen in the presence of ∆GAR is not simply due to the over expression of the EGFP-
tagged construct.  The increase in the nucleoplasmic signal of B23 in the presence of 
exogenously expressed ∆GAR EGFP nucleolin suggests an in vivo interaction between 
B23 with the amino terminal two-thirds of nucleolin.  Previous work supports this 
observation (Li et al., 1996).  The results therefore suggest that ∆GAR has limited or no 
interaction with Nopp140, a slight interaction with fibrillarin, and a significant interaction 
with B23 when stably expressed in CHO cells.  
DISCUSSION 
Expression of ∆GAR Nucleolin in HeLa Cells 
Our lab and others previously showed that the GAR domains of various vertebrate 
nucleolins were required for nucleolar localization, and that nucleolin lacking this GAR 
domain accumulated in the nucleoplasm (Heine et al., 1993; Meβmer and Dreyer, 1993; 
Schmidt-Zachmann and Nigg, 1993).  Chinese hamster nucleolin lacking its GAR 
domain failed to localize to interphase HeLa cell nucleoli (see Fig. 2.1, C and D).  The 
results presented here agree with results from other organisms, namely that the GAR 
domain of nucleolin is required for proper localization of nucleolin to nucleoli.   
The nucleolar localization of nucleolar proteins is presumed to be the result of 
functional associations during ribosome biogenesis.  Specifically, the localization of 
nucleolin to nucleoli is believed to be mediated by binding pre-rRNA; RNase treatment 
induces the release of nucleolin from nucleoli (Schwab and Dreyer, 1997).  The failure of 
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∆GAR to localize to nucleoli is possibly related to its inability to efficiently bind nucleic 
acids (see Chapter 4) (Heine et al., 1993).   
Possible Interactions with Other Non-Ribosomal Nucleolar Proteins in CHO Cells 
 We noticed that cells expressing ∆GAR appeared to have smaller nucleoli than 
non-transfected cells (see Figs. 2.2, 2.3, 2.4, A and C).  This might be due to ∆GAR 
nucleolin interacting with other nucleolar components, and thus causing them to 
relocalize from the nucleolus to the nucleoplasm, thereby decreasing the size of the 
nucleolus.  Enhanced green flourescent protein (EGFP) was fused to the carboxy 
terminus hamster nucleolin (wild type and ∆GAR) in order to leave nucleolin’s amino 
terminus unobstructed.  The amino terminal portion of nucleolin has been shown to be 
involved in interactions with histones, snoRNP U3, and some ribosomal proteins (Erard 
et al., 1988; Ginisty et al., 1998; Bouvet et al., 1998).  
CHO cells were transfected with constructs expressing either wild type or ∆GAR 
EGFP-tagged Chinese hamster nucleolin.  Stable integrations of the plasmids expressing 
the EGFP tagged constructs were selected by G418 resistance.  Cells expressing EGFP-
tagged nucleolins, however, could not be perpetuated indefinitely in cell culture before 
losing expression of EGFP as monitored by fluorescence microscopy.  Loss of wild type 
expression was slow (about 10% of the cells per week).  This is most likely the result of 
cytotoxicity of the EGFP tag, which has been demonstrated for stable expression from 
strong promoters in cell culture (Liu et al. 1999; Gubin et al. 1999).  The loss of 
expression of ∆GAR nucleolin, however, was more acute with a decline rate of 4-5 times 
that of wild type.  This suggests that something other than GFP toxicity was interfering 
with the cells ability to grow and / or maintain expression of EGFP ∆GAR nucleolin.  
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This loss of viability is likely due to interference with ribosome biogenesis as a result of 
∆GAR nucleolin sequestering components needed for ribosome biogenesis in the 
nucleoplasm.    
In order to test the above hypothesis, antibodies to three other nucleolar proteins 
were used on cells expressing ∆GAR EGFP nucleolin.  The three nucleolar proteins 
examined were Nopp140, fibrillarin, and B23. The amount of nucleoplasmic staining of 
the three nucleolar proteins in CHO cells expressing ∆GAR EGFP nucleolin was 
compared to staining in untransfected cells or in cells expressing wild type EGFP 
nucleolin.  Nopp140 appeared to be unaffected by the presence of ∆GAR nucleolin.  
Fibrillarin was more difficult to characterize because although there did appear to be a 
slight redistribution of fibrillarin in the presence of ∆GAR nucleolin, the redistribution 
was weak and inconsistent (see Fig. 2.4).  B23 on the other hand, clearly redistributed to 
the nucleoplasm in the presence of ∆GAR (see Figs. 2.3 and 2.5 respectively). 
Nopp140 is a nucleolar phosphoprotein of 140 kDa.  It consists almost entirely of 
alternating acidic and basic domains.  Nopp140 normally localizes to the DFC of the 
nucleolus and to Cajal bodies.  Similar to other nucleolar proteins, Nopp140 shuttles 
between the nucleus and cytoplasm (Meier and Blobel, 1992).  This shuttling, together 
with the ability of Nopp140 to bind NLSs, suggests a possible a role of Nopp140 in the 
transport of nucleolar components (Meier and Blobel, 1992).  Nopp140 is also a 
component of box C/D and box H/ACA snoRNPs, and it may have a role in the transport 
of snoRNPs to the nucleolus (Yang et al., 2000).  Although the alternating acidic and 
basic stretches common to both nucleolin and Nopp140 provide potential interaction 
surfaces, no interaction has been demonstrated for these two proteins.  Our results also 
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did not indicate an interaction between Nopp140 and ∆GAR in vivo; ∆GAR nucleolin 
failed to redistribute Nopp140 to the nucleoplasm (see Fig. 2.3, H-I). 
Fibrillarin is a highly conserved nucleolar protein.  It consists of an amino 
terminal GAR domain, two central RNA binding domains (RBDs), and a carboxy 
terminal domain that may form alpha helices (Christensen and Fuxa, 1988; Aris and 
Blobel, 1991).  Similar to Nopp140, fibrillarin is associated with box C/D snoRNAs, and 
it localizes to the DFC of nucleoli (Tollervey et al., 1993).  In yeast, fibrillarin is 
implicated in maturation of all rRNAs species, which strongly indicates a role for 
fibrillarin in ribosome biogenesis.  
In the presence of ∆GAR nucleolin, fibrillarin appears to be slightly redistributed 
to the nucleoplasm (Fig. 2.4, H-I).  The redistribution of fibrillarin in the presence of 
∆GAR was, however, weak and inconsistent from cell to cell.  Fibrillarin is known to be 
associated with the U3 snoRNP in mouse, and nucleolin’s amino terminus has been 
shown to directly interact with U3 snoRNA in mouse (Turley et al., 1993; Ginisty et al., 
1998). Although no direct interaction between fibrillarin and nucleolin has been observed 
previously, the slight redistribution of fibrillarin by ∆GAR may be the result of an 
indirect interaction mediated by the U3 small nucleolar RNA (snoRNA). 
B23 is a multifunctional nucleolar protein present in both the DFCs and GCs 
(Ochs et al.1983; Biggiogera et al. 1991).  Similar to other nucleolar proteins (Nopp140 
and nucleolin) the amino terminus of B23 consists of repeating acidic and basic domains. 
Although B23 lacks a consensus RNA binding domain, it can bind nucleic acids, 
presumably through its carboxyl terminus (Dumbar et al., 1989).  B23 shuttles between 
the nucleolus and cytoplasm, and it can bind monopartite SV40-type NLSs, but not the 
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classic bipartite NLSs.  This binding has been demonstrated to be responsible for 
directing viral proteins Rev, Rex and possibly Tat to the nucleolus (Borer et al., 1989; 
Fankhauser et al., 1991 Szebeni et al., 1995).  Non-ribosomal nucleolar proteins, 
nucleolin and p120 have been shown to interact with B23 (Li et al., 1996; Valdez et al., 
1994).  B23 is considered a putative ribosome biogenesis factor based on its localization 
and nucleic acids binding. 
Previous work demonstrated an interaction between nucleolin and B23 by a yeast 
two-hybrid assay and immuno-precipitation (Li et al., 1996).  Deletion analysis identified 
amino acids 194-239 of human B23 as critical for its interaction with nucleolin.  This 
region includes part of the ill-defined, C-terminal region that is responsible for the 
nucleic acid binding ability of B23 (Li et al., 1996; Wang et al., 1994).  Deletion analysis 
identified amino acids 540-628 of human nucleolin as critical for the interaction with 
B23.  This region comprises consensus sequence RNA binding domains 3 and 4.  The 
methods used to demonstrate the interaction between nucleolin and B23 by Li et al. 
(1996) did not exclude the possibility of the interaction being mediated by nucleic acids.  
Furthermore, the domains defined as essential for the interaction between the two 
proteins are both involved in nucleic acid binding. 
B23 was clearly redistributed to the nucleoplasm in the presence of EGFP ∆GAR 
(see Fig. 2.5, H-I), but not by the presence of wild type EGFP-tagged nucleolin.  Thus 
over-expression of the EGFP-tagged wild type nucleolin did not affect endogenous B23.  
RBDs 3 and 4, defined as critical for interaction with B23, are present in ∆GAR 
nucleolin, and therefore one would expect to see an interaction with B23 based on the 
previous data of Li et al. (1996).  The interaction of B23 and nucleolin as reported by Li 
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et al. (1996) did not directly address the requirement for the presence of the GAR 
domain.  Additionally, the interaction seen by Li et al. (1996) could have been mediated 
by nucleic acids.  Our current effort agrees with the work of Li et al. (1996) and extends 
it by suggesting an in vivo interaction between nucleolin and B23 in a vertebrate cell.  
Since the GAR domain of nucleolin is needed for efficient nucleic acid binding, the in 
vivo interaction seen here suggests that the interaction between B23 and nucleolin is not 
mediated by nucleic acids.   
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Chapter 3 
Effect of Methylation Inhibition on Chinese Hamster Nucleolin In Vivo 
INTRODUCTION 
Post-translational modification of proteins allows cells to expand beyond the 
limits imposed by the twenty encoded amino acids.  Just as protein phosphoryation has 
proved to have important implications in protein function, other post-translational 
modifications, such as arginine methylation, may represent a powerful modulator of 
protein function.  Despite methyl arginines being discovered over 30 years ago, only very 
recently has any functional significance been ascribed to this post-translational 
modification.  Arginines destined for methylation are typically located within specific 
motifs depending on the type of methylated end product generated.  Three types of 
methylated arginines are generated in vivo, monomethylarginine, symmetric 
dimethylarginine and asymmetric dimethylarginine (see Fig. 1.5).  Symmetric 
dimethylarginines are located in RG dipeptide repeats or RXR motifs.  Asymmetric 
dimethylarginines are located in RGG motifs that are often clustered together with 
interspersed aromatic amino acids (usually phenylalanine) in a protein domain known as 
the glycine and arginine rich (GAR) domain (Lischwe et al., 1981; McBride and Silver, 
2001).   
The recent discoveries regarding the functional significance of arginine 
methylation have been mainly for the symmetrically dimethylated form.  These 
discoveries include protein-protein interactions related to cell signaling, transcription and 
protein sorting (McBride and Silver, 2001; Friesen et al., 2001).  Myelin basic protein 
(MBP), a major component of the myelin sheath, was the first protein known to be 
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symmetrically dimethylated.  Only one arginine appears to be methylated corresponding 
to residue 107 of the bovine sequence.  MBP is located in compact myelin and interacts 
with opposed cytoplasmic membrane surfaces.  Symmetric dimethylation may play an 
essential role in maintaining of the layered membrane of the myelin sheath (Gary and 
Clarke, 1998).  
Very recently other proteins were shown to contain sDMA.  These include 
splicing factors SmD1, SmD3 and signaling proteins Stat1 and Sam68.  For these 
proteins, methylation appears to be involved in protein-protein interactions.  In the case 
of SmD1 and SmD3, symmetric dimethylation increases binding to the SMN protein.  
Alternatively, binding to target proteins PIAS1 and SH3 domain-containing proteins by 
Stat1 and Sam68, respectively, decreased upon symmetric dimethylation. 
Most methlyated arginines, however, are asymmetrically dimethylated.  To date, 
no clear functional significance is known for asymmetrically dimethylated proteins 
involved in ribosome biogenesis (i.e. nucleolin and fibrillarin which are among the most 
highly methylated cellular proteins).  Histones were among the first proteins identified as 
substrates for partially purified Type I protein arginine methyltransferases (Paik and Kim, 
1968).  It is now known that although they contain aDMA, histones are very poor 
substrates compared to GAR domain-containing proteins like hnRNP A1, nucleolin and 
fibrillarin.   
Both lysine and arginine methylation of histone tails appears to play roles in the 
epigenetic control of gene expression through involvement in the “histone code” 
mediated chromatin remodeling (Jenuwein and Allis, 2001).  Recent cloning of several 
mammalian protein arginine methyltransferases has allowed the identification of 
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previously unknown substrates for methylation.  Coactivator-associated arginine 
methyltransferase 1 / protein arginine methyltransferase 4 (CARM1/PRMT4) was 
identified as a transcriptional co-activator of hormone-induced gene activation.  The 
ability to enhance transcription is mediated through the family of p160 coactivators 
(SRC-1, GRIP1/TIF2, pCIP/RAC3/ACTR/AIB1/TRAM2), specifically by way of its 
interaction with GRIP1 (Chen et al., 1999).  Xu et al. (2001) demonstrated that nuclear 
hormone-dependent transcriptional activation by CARM1 is via methylation of arginines 
in histone H3 and CBP/p300 (CREB binding protein).  Additionally, CARM1 acts as a 
transcriptional repressor of cyclic AMP transcriptional activation mediated by cyclic 
AMP response element binding protein (CREB).  Methylation of specific arginine 
residues in p300 (R580) and in CBP (R600) blocks binding of CREB.  The methylated 
arginine, however, does not exist in a known methylation motif.  This is, however, the 
first detailed mechanism for asymmetric dimethylation function, and it represents the first 
function of aDMA in vertebrates (Xu et al., 2001). Other than the role of asymmetric 
methylation of arginine in CARM1 in transcriptional control, the functional significance 
of asymmetric dimethylation in vertebrates is generally unknown for aDMA containing-
RNA binding proteins.   
Methylation of yeast shuttling hnRNP proteins Npl3 and Hrp1 facilitates their 
export from the nucleus.  Both proteins bind poly A+ RNA, and blocking their 
methylation dependent nuclear export is correlated with a nuclear accumulation of poly 
A+ RNA.  These results implicate protein methylation as having a role in nucleo-
cytoplasmic shuttling (Gary et al., 1996; Shen et al., 1998).   
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High molecular weight fibroblast growth factor-2 (HMW FGF-2) (an alternative 
22/24 kDa form of the protein produced by translation from an alternative CUG start 
codon) is localized to the nucleus as opposed to the normal 18 kDa form which is 
cytoplasmic.  The high molecular weight form of FGF-2 has five to eight arginines 
depending on the particular form produced.  These arginines are located in classic RGG 
motifs in an internal GAR domain and are known to be asymmetrically dimethylated.  
Deletion of the GAR domain or treatment with methyltransferase inhibitors, 5-deoxy 5′ 
methythioadenosine (MTA) or 3-deaza-adenosine (DAA), causes HMW FGF-2 to shift 
its intracellular steady state concentration from the nucleus to the cytoplasm (Pintucci et 
al., 1996; Klein et al., 2000).  The localization of another aDMA containing protein, 
hnRNP A2, is also shifted from the nucleus to the cytoplasm upon deletion of its GAR 
domain, or upon treating cells with methyltransferase inhibitors (Nichols et al., 2000).  
Methylation is therefore thought to be responsible for the nuclear localization of the 
protein.   
The previous chapter demonstrated that the GAR domain of Chinese hamster 
nucleolin is required for proper localization of nucleolin to interphase nucleoli, indicating 
that the GAR domain is involved in targeting nucleolin to nucleoli.  Since the GAR 
domain is involved in localization and aDMAs are located solely within this domain, 
asymmetric dimethylation may be involved in protein targeting.  Additionally, previous 
results had demonstrated a potential link between methylation and the cellular 
localization HMW FGF-2 and hnRNP A2, thus reinforcing this idea.  This chapter 
describes the relocalization of nucleolin from nucleoli to the nucleoplasm in the presence 
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of the same methyltransferase inhibitors.  The observation supports the hypothesis that 
nucleolin methylation regulates its intracellular localization. 
MATERIALS AND METHODS 
MTA and DAA Inhibition of Methylation  
 HeLa cells were grown on coverslips in six well culture plates at 37° C in a 5% 
CO2 atmosphere.  The cells were grown in Dulbecco’s Modified Eagle Medium (DMEM) 
(Life Technologies Gibco BLR, Gaithersburg, MD) supplemented with 10% fetal calf 
serum and 50 µg/ml gentamycin.  HeLa cells were transfected with the pBK-CMV 
expression vector encoding a myc-tagged wild type hamster nucleolin (pMCN).  
Transfection was by the calcium phosphate method of Chen and Okayama (1988) using 
N,N-bis(2-hydroxyethyl)-2-aminoethanesulfonic acid.  After adding the Ca2+-DNA 
solution, cells were cultured at 35°C in a 3% CO2 atmosphere for 18 hours.  The calcium-
DNA precipitate was washed off with sterile 1 x PBS, and the cells allowed to express 
tagged nucleolin for 24 hours in DMEM with 10% FCS at 37° C in 5% CO2 prior to 
treatment with methyltransfease inhibitors.   
Methyltransfease inhibitors MTA and DAA were purchased from Sigma-Aldrich, 
Inc. (St. Louis, MO).  Cells were placed in medium containing 3 mM MTA or 30 µM 
DAA for up to three hours at 37° C and in a 5% CO2 atmosphere.  Some cells were fixed 
and stained immediately upon removal of MTA, while others were allowed to recover in 
fresh medium for up to two hours.  Some HeLa cells were also placed in medium 
containing 100 µg/ml cycloheximide for three hours alone, or for two hours in the 
presence of cycloheximide prior to treatment with MTA for one hour. Cells were fixed in 
2.5% paraformaldehyde in 0.5 x PBS for 2 hours at room temperature, followed by three 
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washes in 1 x PBS. Cells were made permeable with 0.5% Triton X-100 in 1 x PBS for 5 
minutes, and preblocked with 10% horse serum in 1 x PBS at room temperature for 1.5 
hours.  Cells were stained with anti-myc mouse monoclonal antibody 9E10 hybridoma 
supernatant for 1 hour at room temperature followed by washing and restaining with 
fluorescein-conjugated goat anti-mouse IgG (Pierce, Rockford , Il) for 1 hour at room 
temperature.  A Zeiss Axioskop was used to visualize cells by standard phase contrast 
and immuno-flourescence microscopy.  Pictures were taken with Kodiak T-Max 400 
speed black and white film. 
Conformation of Inhibition of Protein Synthesis by Cycloheximide 
 HeLa cells were cultured as described above, except that no coverslips were 
included in the wells, and the seeding density was increased to 9.4 X 105 cells/well.  
Three wells were treated with 100 µg/ml cycloheximide for one hour prior to incubation 
of all six wells with 50 µl of [14C] labeled amino acid mix (Gly, Ala, Pro, Val, Leu, Iso, 
Thr, Glu, His, Arg, specific activity of 1 µCi/ul) in 1 x PBS for 20 minutes.  To remove 
the cells from the wells, they were treated with 0.25% trypsin in 1 x PBS either with or 
without 100 µg/ml cycloheximide.  The cells were washed twice in 1 x PBS.  They were 
then resuspended in 50 µl of 0.1% Triton X-100 and vortexed vigorously followed by 
homogenization with 50 strokes of a disposable dounce homogenizer in a 1.5 ml 
Eppendorf tube.  The entire sample was then applied to a Whatman GF-A glass micro-
fiber filter and left to air dry for 25 minutes.  The filters were placed in ice-cold 10% 
TCA for one minute, followed by treatment with hot (∼99°C) 10% TCA for 10 minutes to 
break the amino acyl-tRNA bond.  Filters were then rinsed in 100% ethanol followed by 
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ether under gentle suction.  Each filter was placed in 10 mls of scintillation fluid and 
assayed using a LS 6000IC Beckman (Model # LSBK-1C) scintillation counter.        
RESULTS 
Effect of Methyltransferase Inhibitors MTA and DAA on Nucleolin in HeLa Cells 
Chapter 2 described how the GAR domain of Chinese hamster nucleolin is 
necessary for nucleolar localization.  The GAR domain contains several conserved 
dimethylarginines, the functions of which remain unknown.  Work by Pintucci et al. 
(1996), Klein et al., (2000) and Nichols et al. (2000) indicated arginine methylation 
affects intracellular distribution of HMW-FGF2 and hnRNP A2.  A review by Ginisty et 
al. (1999) of nucleolin also suggested that methylation might play a role in its localization 
to nucleoli. To explore this possibility, HeLa cells were transfected with plasmids 
encoding myc-tagged versions of wild type nucleolin.  Methylation of the transfected 
cells was blocked using MTA and DAA, known protein methyltransferase inhibitors (see 
Fig 3.1) (Pintucci et al., 1986).   After as little as one hour in culture medium containing 3 
mM MTA, the myc-tagged nucleolin had redistributed to the nucleoplasm, and nucleoli in 
most cells appeared fragmented (see Fig. 3.2, and 3.3, C and D). Redistribution of 
nucleolin to the nucleoplasm was also seen in cells treated with DAA.  The effect of 
DAA, however, was slower than MTA with some nucleolin redistribution seen in two 
hours and strong redistribution observed after 18 hrs (see Fig 3.2, D and E).  
The remnant nucleoli in cells in which nucleolin had redistributed to the nucleoplasm 
exhibited detectable amounts of fibrillarin as determined by antibody staining (see Fig 
3.2, I and J).  This indicates that not all aDMA containing nucleolar proteins relocalize as 
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Figure 3.1 Structure of S-adenosylmethionine (SAM), 5’-deoxy 5’methylthioadenosine (MTA),
and S-adenosylhomocysteine (AdoHcy). SAM donates the methyl group indicated in red to X
which represents a methyl acceptor. The methyltransferase inhibitor, MTA, is an analog of
SAM. The methyltransferase inhibitor DAA acts to inhibit the enzyme adenosylhomocysteine
hydrolase, thus preventing the breakdown of AdoHcy into homocysteine and adenosine. The








Effects of blocking SAM-dependent methylation using the methyltransferase
inhibitors, MTA and DAA. HeLa cells were transfected with a cDNA encoding -tagged full-
length wild-type hamster nucleolin ( - ). -tagged nucleolin properly localizes to HeLa cell
interphase nucleoli ( and ). After treatment for 2 hours with 3mM MTA in the culture
medium, -tagged nucleolin redistributes to the nucleoplasm ( and ). The same
redistribution is seen after 18 hours of treatment with DAA ( and ). Endogenous fibrillarin
localizes to nucleoli in untreated cells is













-tagged nucleolin properly localizes to interphase HeLa
cells ( and ). Treatment with 3 mM MTA for 2 hours caused the -tagged nucleolin to
redistribute to the nucleoplasm ( and ). Within one hour after removal of MTA from the
culture medium, -tagged nucleolin re-associated with interphase nucleoli ( and ).
Addition of 100 g/ml cycloheximide to the culture medium had no effect on the distribution of
-tagged nucleolin after three hours ( and ). Pre-treatment of HeLa cells with 100
cycloheximide for 2 hours to block protein translation had no effect on the MTA-mediated










Since the mode of action was more direct and the effect more rapid with MTA 
than with DAA, MTA was used in all subsequent experiments.  When treated cells were 
allowed to recover in fresh medium lacking MTA, myc-tagged nucleolin reassociated 
with nucleoli in as little as 30 minutes, and all cells showed nucleolin reassociation 
within two hours (see Fig. 3.3, E and F).   
The apparent redistribution of nucleolin after MTA treatment could have been due 
to the affinity of newly synthesized and unmethylated myc-tagged nucleolin to enter the 
nucleus by not the nucleolus.  To test this possibility, we used cycloheximide to block 
translation prior to treatment with MTA.  Pretreatment of HeLa cells with 100 µg/ml 
cycloheximide for one hour was determined to be a sufficient block for all protein 
translation (see Fig 3.4).  This concentration of cycloheximide had no effect on 
nucleolin’s association with nucleoli (see Fig. 3.3, G and H).  When HeLa cells were 
treated with MTA after pretreatment with cycloheximide, myc-tagged nucleolin was 
again observed to redistribute to the nucleoplasm (see Fig.3.3, I and J).   This indicates 
that the nucleoplasmic signal was not due to nascent protein entering the nucleus, but 
instead a redistribution of nucleolin that had been associated with nucleoli prior to the 
addition of MTA to the culture medium.  The result is consistent with methylation 
inhibitors causing the redistribution of aDMA containing proteins. 
DISCUSSION 
Both methyltransferase inhibitors used in this study, MTA and DAA, 
demonstrated a pronounced effect on the behavior of exogenously expressed myc-tagged 
hamster nucleolin.  After only one hour of MTA treatment, exogenous nucleolin had 
redistributed to the nucleoplasm.  In some cells the nucleolar remnants appeared as dark 
Figure 3.4 Graph showing the inhibition of protein synthesis by cycloheximide. HeLa cells
were either treated with 100 g/ml cycloheximide for one hour or left untreated. The amount of
[ C] labeled amino acids are represented as a percent incorporation compared to untreated
HeLa cells. Protein synthesis is almost completely blocked, with treated cells incorporated only



































holes in the nucleoplasm indicating a complete lack of nucleolin (see Fig. 3.3, C and D).  
MTA also affected the morphology of the interphase HeLa cell nucleoli, causing them to 
become fragmented.  This effect may be directly due to the loss of nucleolin and B23. 
 DAA was much slower acting than MTA with 12-16 hours being required for 
complete redistribution of the exogenous nucleolin.  The difference in the behavior of the 
two methyltransferase inhibitors probably reflects their different modes of action.  MTA 
is a structural homolog of S-adenosyl-L-methionine (SAM), the universal methyl donor.  
MTA, therefore, most likely inhibits methylation by directly competing with SAM in 
binding the active site of protein methyltransferases.  DAA, on the other hand, inhibits 
methylation indirectly by blocking adenosylhomocysteine hydrolase, the enzyme 
responsible for converting S-adenosylhomocysteine into adenosine and homocysteine 
(see Fig 3.1).  Excess S-adenosylhomocysteine exerts considerable end-product inhibition 
on SAM dependent enzymes (Chiang, 1996).  The delayed effect of DAA is most likely 
due to the lag time required to increase intracellular concentrations of 
adenosylhomocyteine to levels capable of inhibiting the methyltransferases.  These 
results agree with experiments on other aDMA containing-proteins, HMW FGF2 and 
hnRNP A2, in which a block in their methylation adversely affects their intracellular 
distribution (Pintucci et al. 1996; Nichols et al., 2000).     
Not all aDMA containing nucleolar proteins are affected by treatment with the 
methyltransferase inhibitor, MTA.  The localization of endogenous fibrillarin appears 
unaffected by treatment with MTA (see Fig. 3.2, I and J).  This is somewhat surprising 
since fibrillarin contains a GAR domain that is highly methylated in vivo (Christensen 
and Fuxa, 1988).  The GAR domain of fibrillarin is near the amino terminus of the 
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protein, and the domain is positioned much more internally compared to the GAR domain 
of nucleolin.  Unlike the GAR domain of nucleolin, the GAR domain of fibrillarin has 
never been shown to be required for nucleic acid binding or nucleolar localization.  The 
differences in the behavior of nucleolin and fibrillarin in the presence of MTA may 
reflect distinct functional differences between their respective GAR domains. 
The redistribution of exogenous nucleolin by MTA suggests that arginine 
methylation may be involved in maintaining the nucleolar localization of nucleolin.  
Redistribution of exogenous nucleolin due to treatment with MTA occurs quickly, taking 
approximately one hour.  When MTA is washed out, nucleolin returns to interphase 
nucleoli in approximately the same one hour time period required for MTA to redistribute 
nucleolin to the nucleoplasm.  If nucleolin’s nucleolar localization is due to the state of its 
arginine methylation, then one of two possibilities exists.  In the first possibility, the 
protein arginine methyltransferase responsible for nucleolin methylation is nuclear, and 
this activity must be maintained to keep nucleolin localized to nucleoli.  Alternatively, 
the loss of nucleolin localization from nucleoli may be the result of nascent unmethylated 
protein entering the nucleus and being unable to localize to nucleoli without the presence 
of aDMAs in the GAR domain.  The second scenario would require that the cellular 
turnover of nucleolin be very rapid.   
In order to distinguish between these two possibilities, we determined conditions 
to block protein synthesis (see Fig 3.4).  In the presence of cycloheximide, exogenous 
nucleolin behaved identically in the presence of MTA, redistributing to the nucleoplasm 
(see Fig 3.3, I and J).  This result indicates that the nucleolin that redistributed to the 
nucleoplasm was originally localized to nucleoli prior to the addition of the MTA.  Thus, 
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the staining of the nucleoplasm is not the result of unmethylated nascent nucleolin 
entering the nucleus and being unable to localize to nucleoli.  Assuming that the 
redistribution of nucleolin in the presence of MTA is directly related to blocking arginine 
methylation in the GAR domain of nucleolin, the nucleolar localization of nucleolin is 
therefore dependent on arginine methylation.   
If the methylation of nucleolin is required for its nucleolar localization and 
blocking methylation results in redistribution of nucleolin to the nucleoplasm, then 
nucleolin must be in a cycle of methylation and demethylation in vivo.  The shuttling of 
nucleolin is far slower than the kinetics of nucleolar reassociation observed after removal 
of MTA from the medium.  Therefore, the protein arginine methyltransferase responsible 
for nucleolin methylation would need to be nuclear in order to meet the kinetics of 
redistribution and relocalization if arginine methylation is controlling nucleolin 
localization.  The drawback in these assumptions is the belief that protein methylation is 
thought to be irreversible (Clarke, 1998). 
Protein arginine methyltransferase 1 (PRMT1) is responsible for 90% of type I 
protein arginine methyltransferase activity in vertebrate cells (Tang et al., 2000b).  
PRMT1 is localized primarily to the nucleus with small amounts detected in the 
cytoplasm (Tang et al., 1998).  It is not known if nucleolin is an in vivo substrate for 
PRMT1; however, PRMT1 does exhibit strong methyltransferase activity toward RGG 
motifs in vitro.  The nuclear localization of the PRMT1 does concur with the hypothesis 
that nucleolin may be demethylated, and that the unmethylated form of nucleolin is 
unable to associate with the interphase nucleoli.  There is, however, no evidence of an 
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enzymatic activity related to demethylation, or that post-translationally methylated 
proteins can be demethylated other than by proteolysis.   
MTA must block global methylation in the cell.  This includes DNA methylation, 
RNA methylation and various forms of protein methylation.  Therefore, the effects that 
MTA has on nucleolin localization may not be directly related to nucleolin’s methylation 
state, but rather MTA’s effects may be indirect due to lack of methylation of other 
nucleolar substrates.  For example, another nucleolar substrate could be pre-rRNA.  The 
2'-O-methylation of pre-rRNA that is mediated by box C/D snoRNPs and fibrillarin 
should also be inhibited by MTA, since this methylation is a SAM-dependent event 
(Chiang et al., 1996).  Nucleolin’s interaction with pre-rRNA may be directly dependent 
on the methylation state of pre-rRNA, either indirectly through a mediator of ribose 
methylation or directly through structural changes induced in the pre-rRNA by 
methylation of sugars.  Fibrillarin is known to be involved with the 2'-O-ribose 
methylation of pre-rRNA.  Perhaps fibrillarin, which is not redistributed upon treatment 
with MTA, remains associated with pre-rRNA until methylation in complete.  
Alternatively, nucleolin may bind the pre-RNA only once the RNA is methylated.     
Blocking methylation of pre-rRNA may also prevent the further production of 
pre-rRNA by a feedback mechanism involving RNA pol I.  When transcription of rRNA 
is inhibited by actinomyosin D, nucleoli disassemble and nucleolin redistributes to the 
nucleoplasm, indicating the need for active transcription to maintain association of 
nucleolin nucleolar morphology (Escande et al., 1985; DiMario unpublished results).  
The disruption of nucleolar morphology and the redistribution of nucleolin in the 
presence of MTA could be the result of MTA blocking the methylation of pre-rRNA and 
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therefore its maturation.  A block in pre-rRNA maturation may then feedback to stop 
further transcription of polymerase I.  There are probably a number of additional ways 
that blocking methylation may produce the observed effects, and for this reason an 
experiment that directly addresses the effect of nucleolin’s arginine methylation is 
presented in Chapter 4.   
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Chapter 4 
Characterization of an Arg→Lys Substituted Nucleolin 
INTRODUCTION 
The research performed in Chapter 3 suggests arginine methylation is important 
for the sub-cellular localization of nucleolin, and therefore, its function.  The 
redistribution of nucleolin, however, might not be directly related to the effects of 
blocking nucleolin methylation with MTA or DAA.  Instead a block in the methylation of 
other nucleolar components may cause nucleolin to redistribute.  Also, due to relatively 
large intracellular pools of SAM, we were unable to biochemically correlate the effects of 
MTA with the state of nucleolin methylation in vivo. In this chapter I describe attempts to 
directly test the supposition that arginine methylation plays a role in the localization of 
nucleolin to nucleoli as initially proposed by Ginisty et al. (1998). 
 Dimethylarginine exists as two distinct forms in vivo, symmetric and asymmetric 
(see Fig. 1.5).  Symmetric arginines are located in RG dipeptide repeats or RXR motifs.  
Asymmetric arginines are typically located in RGG motifs that are often clustered 
together with interspersed aromatic amino acids in a protein domain known as the glycine 
arginine rich (GAR) domain (McBride and Silver, 2001; Lischwe et al., 1981).   
The functional significance of symmetric arginine methylation includes protein-
protein interactions, transcription and protein sorting (McBride and Silver, 2001; Friesen 
et al., 2001). Symmetric methylation of myelin basic protein (MBP) may play an 
essential role in maintaining the correct membrane-associated position of MBP (Gary and 
Clarke, 1998).  The protein-protein interactions involving splicing factors SmD1 and 
SmD3, as well as signaling proteins Stat1 and Sam68, appear to be modulated by 
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symmetric arginine dimethylation (McBride and Silver, 2001).  For example, symmetric 
dimethylation of SmD1 and SmD3 increases binding to the survival of motor neuron 
(SMN) protein.  Alternatively, binding to target proteins PIAS1 and SH3 domain-
containing proteins by Stat1 and Sam68 respectively, decreased upon symmetric 
dimethylation of Stat1 and Sam68. 
The function of asymmetric methylation is known in only one case.  When the 
KIX domain of the CBP/p300 (CREB binding protein) is asymmetrically dimethylated, it 
is no longer able to interact effectively with the KID domain in the cyclic AMP response 
element binding protein (CREB).  Thus, the interaction between CBP/p300 and CREB is 
disrupted.  CBP/p300, however, is very atypical for aDMA-containing proteins.  Its 
arginine is not located in a classic RGG motif, and it is the substrate for a very specific 
protein arginine methyltransferase, CARM1/PRMT4 (Xu et al., 2001).  All other known 
aDMA-containing proteins are methylated in RGG motifs that are typically found in a 
GAR domain.  Proteins containing RGG motifs are substrates for the major cellular 
protein arginine methyltransferase, PRMT1, which is responsible for 90% of the type I 
protein arginine methyltransferase activity in the cell (Tang et al., 2000a; Tang et al., 
2000b).  GAR domain containing proteins are also among the most highly methylated 
cellular proteins (Gary and Clarke, 1998).   
In budding yeast there appears to be only one protein arginine methyltransferase 
(Hmt1/Rmt1).  Deletion of the HMT1 gene eliminates all NGNG-dimethylarginine 
residues (Zobel-Thropp et al., 1998).  Methylation of shuttling hnRNP proteins Npl3 and 
Hrp1 facilitate their export out of the nucleus.  Both proteins bind poly A+ RNA and their 
methylation-dependent nuclear export is correlated with a nuclear accumulation of poly 
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A+ RNA, implicating methylation in the export of mRNA in yeast.  Deletion of the 
HMT1 gene is not lethal; instead it results in a slow growth phenotype (Gary et al., 
1996).   
CBP80 and CBP20 form the cap binding complex (CBC) associated with the 5' 
trimethylguanosine cap of mRNA.  The CBC mediates efficient pre-mRNA splicing, as 
well as snRNA export.   Yeast strains bearing disruptions in NPL3 and cap binding 
protein 80 (CBP80) are viable.  However, deletion of the HMT1 gene in these stains 
results in a lethal phenotype (Shen et al., 1998).  The synthetic lethality of the HMT1 
deletion in ∆CBP80 and ∆NPL3 backgrounds, suggests that Cbp80p, Hrp1p, Npl3p all 
act in a linear pathway for the transport of RNA, each step being affected by Hmt1p.  
However, export of another methylated hnRNP shuttling protein, Hrb1, was not affected 
by deletion of HMT1 (Henry and Silver, 1996; Shen et al., 1998).  So, the effects of 
methylation are still not clear. 
HMW FGF is another protein that contains aDMAs.  It has classic RGG motifs 
within an internal GAR domain.  Methyltransferase inhibitors have implicated 
methylation in shifting the intracellular localization of HMW FGF from the nucleus to 
cytoplasm (Pintucci et al., 1996).  The nuclear protein hnRNP A2 is involved in mRNA 
processing and splice site selection.  It contains classic RGG motifs that are 
asymmetrically dimethylated in vivo.  Removal of the GAR domain or inhibition of SAM 
dependent methylation shifts the cellular localization of hnRNP A2 from the nucleus to 
the cytoplasm, again suggesting a role for aDMA in subcellular localization (Nichols et 
al., 2000). 
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The results presented in Chapter 2 demonstrated that the GAR domain of hamster 
nucleolin is required for proper localization, indicating that the GAR domain is involved 
in targeting of wild type nucleolin to nucleoli.  The results presented in Chapter 3 
supported this idea by demonstrating a similar redistribution of nucleolin to the 
nucleoplasm in response to the methyltransferase inhibitors, MTA and DAA.  
Additionally, previous results by others demonstrated a potential link between 
methylation and the cellular localization of two of the aDMA-containing proteins, HMW 
FGF-2 and hnRNP A2 (Pintucci et al., 1996; Nichols et al., 2000).  Experiments 
described in this chapter directly tests the hypothesis that methylation is required for 
nucleolin’s localization to nucleoli. 
MATERIALS AND METHODS 
Generation of the Arg→Lys Substituted Mutant of Chinese Hamster Nucleolin 
The plasmid, 21R CHO WT (see Chapter 2 and Appendix B), was digested with 
Nco I and EcoR I at an internal Nco I site (+1886) and a C-terminal EcoR I site located in 
the polylinkers region of 21R CHO WT to generate a 452 bp DNA fragment encoding the 
GAR domain and the 3' UTR.  The fragment was ligated into myc-6-D digested with the 
same restriction enzymes.  Ligations and transformations were preformed following 
standard protocols.  The final construct was called 21R CHO GAR WT (see Appendix 
B).  All mutagenesis was preformed using this 21R CHO GAR WT subclone and its 
subsequent derivatives.  The codons for all ten arginines within the GAR domain of the 
hamster nucleolin cDNA were changed to encode lysine.  Oligonucleotides encoding the 
site-specific mutations were synthesized at GeneLab, School of Veterinary Medicine, 
Louisiana State University, Baton Rouge, LA.  The four oligonucleotides named A2 (5'-
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GCCAAACCTAAGGGTGAAGGTGGCTTTGGTGGCAAAGGTGGAGGCAAAGGA 
GGTTTTGGG -3'), B (5'-TCCACCTTTGCCTCCTCCTTTTCCACCACCTTGCCCCC -
3'), C2 (5' - GGAGGCAAAGGTGGATTTGGCGGCAAAGGCAAGGGCGGC - 3'), and 
D2 (5' - GGCTTGAAGTCTCCTCCTCCTCCTCCTCCTTTGCCACCTTTGAAGCCTC 
CTTTACCTCC - 3') covered arginines 1-2, 2-3, 4-7 and 8-10, respectively (see Fig 4.1).  
A variation of the polymerase chain reaction (PCR) first described by Mullis et al. (1986) 
was used to make the base changes.   
The first PCR reaction used 21R CHO WT GAR as template and primers A2 and 
B to generate megaprimers.  The megaprimers were then used in a second PCR reaction 
to generate a full length product that should have had sites 1-5 changed to encode lysine.  
After sequencing, it was realized that the product of the two step PCR reaction was 
heterogeneous, with one strand containing the A series (arginines 1 and 2) and the other 
strand containing the B series (arginines 3-5) (see Appendix B).  The PCR product was 
subcloned back in myc-6-D using the Nco I and EcoR I sites, and the ligated product was 
introduced into competent E. coli using standard protocols.  When the plasmid (21R 
CHO GAR B) was replicated in E. coli, the mismatched bases were recognized by the 
cell’s DNA repair machinery and randomly repaired based on one of the two stands.  In 
the case of sites 1, 2, and 5, the strand encoding the wild type sequence was used as the 
template.  In the case of sites 3 and 4, the mutagenized strand was used as the template, 
thus changing the arginine codons to lysine.   
A subsequent PCR reaction used 21R CHO GAR B as the template with primers D2 
(arginines 8-10) and T7 in the polylinker of the plasmid.  Primer D2 contained a BsmA I 



































































































































































































































































































































































































































Figure 4.1 Location and orientation of primers used in PCR-based site directed mutagenesis.
The sequence represents the entire subcloned GAR cDNA ligated into -6-D. The
nucleotides in red ( ) represent introduced mutations in the cDNA corresponding to Arg Lys











BsmA I) into myc-6-D and named 21R CHO GAR B/D.  The next PCR reaction used 
21R CHO GAR B/D as the template and primers A2 (arginines 1 and 2) and T3 in the 
polylinker of the plasmid.  Primer A2 contained a Bsu36 site used for cloning purposes.  
The resulting PCR product was cloned into myc-6-D and named 21R CHO GAR A/B/D. 
The final PCR reaction used 21R CHO GAR A/B/D as the template.  Primer C 
(arginines 5-7) contained no useful cloning site.  Therefore, primer C and primer T3 from 
the polylinker of the plasmid were used to created a megaprimer during the first 15 PCR 
cycles after which primer T7 was added.  Two PCR products were generated: those that 
had a wild type C series (arginines 5-7) due the amplification during the first 15 cycles 
and those that had a mutagenized C series (see Appendix B)   
PCR reactions were carried out in a Perkins-Elmer Cetus DNA Thermal Cycler.  
Final primer concentrations for all reactions were 1-2 µM, and template DNAs were 
approximately 50 ng of a 812 base pair Pvu II - Pvu II fragment from the various 21R 
CHO GAR subclones.  Vent® DNA polymerase was purchased from New England 
Biolabs (Beverly, MA).  Buffer and dNTP concentrations were set according to New 
England Biolab’s recommended protocols for Vent® DNA polymerase.   The cycling 
program was: 94°C for 5 minutes, 55°C for 1 minute, and 72°C for 20 minutes for one 
cycle, followed by 40 cycles of 94°C for 1 minute, 55°C for 1 minute, 72°C for 3 minutes 
and 30 seconds.  A final extension at 72°C for 15 minutes was used for all PCR reactions.  
Cloning and transformations were preformed according to standard protocols.  Single 
stranded DNA from mutagenized clones was prepared using M13 helper phage according 
to Ausubel et al. (1993).  Site mutations were confirmed by dideoxy sequencing using a 
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United States Biochemical (Cleveland, OH) Sequenase 2.0 kit, following the 
manufacture’s recommended protocols (see Fig 4.2).  
After sequencing to confirm the steps of mutagenesis, only the fully substituted 
GAR domain was pursued.  Both the wild type (21R CHO GAR) and Arg→Lys 
substituted GAR subclones (21R CHO GAR A2BCD2) were digested with Nco I and 
EcoR I to liberate a 452 base pair fragment containing the respective GAR domains.  The 
fragments were gel purified and ligated into the pET30a expression vector (Novagen, 
Madison, WI) that had been previously digested with the same restriction enzymes.  
Ligation placed the respective GAR domains behind and in frame with a histidine tag.  
The 452 base pair fragment from 21R CHO GAR A2BCD2 was also cloned back into the 
full length nucleolin cDNA at the Nco I (+1886 in CHO cDNA) and EcoR I sites in 21R 
CHO.  To allow for expression in eukaryotic systems, the DNA encoding the myc-tagged 
Arg→Lys substituted mutant nucleolin in 21R CHO MUT was cloned into the expression 
vector, pBK-CMV (Stratagene, La Jolla, CA) using Xho I and Xba I sites common to 
both polylinker regions. 
Hmt1p and GAR Peptide Purification From E. coli 
The yeast protein arginine methyltransferase, Hmt1p/Rmt1 (Henry and Silver, 
1996), from Schizosaccharomyces cerevisiae, was a kind gift from Dr. Michael Henry. 
The HMT1 cDNA was provided in the pGEX 4T-1 vector (Pharmacia Peapack, N.J.) 
behind and in frame with a Glutathione-S-transferase (GST) tag.  For compatibility with 
the affinity purification system used in our laboratory, the HMT1 cDNA was moved from 
the pGEX vector and ligated into the pET30a expression vector (Novagen, Madison WI).  























Figure 4.2 Autoradiograms of sequencing gels confirming the specific changes in the cDNA
that encodes the GAR domain of Chinese hamster nucleolin. The numbers indicate the sites of




located in the polylinker regions of pGEX 4T-1.  The resulting 1.9 kb fragment was 
ligated into pET30a which had been cut with BamH I and Xho I restriction 
endonucleases, placing the HMT1 cDNA behind and in frame with the DNA segment of 
pET30a that encodes a histidine tag.  The resulting construct was named His-Hmt1. 
The His-Hmt1 construct was introduced into competent BL21(DE3)pLys S E. coli 
expression cells that were purchased from Novagen (Madison, WI).  XL1-Blue and 
BL21(DE3)pLys S cells containing pGEX-Hmt1 and His-Hmt1, respectively, were 
grown to an O. D.600  nm of 0.65 in Lauria Bertani (LB) medium containing 100 µg/ml 
ampicillin for the pGEX vector or 30 µg/ml kanamyocin and 15 µg/ml chloramphenicol 
for the pET30a vector.  Cultures were then induced with 0.5 mM or 1 mM isoproyl-β-D-
thiogalactopyranoside (IPTG) respectively, for 3.5 hours at 37° C.  Cells were pelleted at 
6000 x g at 4° C for 15 minutes and then resuspended in 15 mls of 50 mM Tris [pH 8.0], 
2 mM EDTA per 100 mls of original culture volume.  The cells were repelleted, and 
stored overnight at -20°C as a semi-dry pellet.  Upon thawing, the cells were resuspended 
in 1 ml (per 50 ml of original culture) of 1 x binding buffer (5 mM imidazole, 500 mM 
NaCl, 20 mM Tris-HCL [pH 7.9]). Cells were lysed by sonication with six 30 second 
pulses on a setting of 4 at 50% duty cycle (Heat Systems-Ultrasonics Cell Disruptor, 
model CW-225 R).  The lysate was centrifuged at 20,000 x g for 15 minutes to pellet cell 
debris, and the soluble fraction (supernatant) was passed through a 0.45 µm filter 
(Millipore, Bedford, MA).  The filtrate was passed through the appropriate affinity 
column, either a glutathione sepharose 4B pre-packed column (Pharmacia Peapack, N.J.) 
or a His-bind resin column (Novagen, Madison, WI) (1 ml of bed volume per 50 mls of 
original culture).  The columns were washed with 25 mls of binding buffer, and then 15 
 90 
mls of wash buffer (60 mM imidazole, 500 mM NaCl, 20 mM Tris [pH 7.9]).  The GST-
Hmt1 fusion protein was eluted from the glutathione sepharose column with 5 mls of 10 
mM glutahinone, 50 mM Tris [pH 8.0]. The His-tagged Hmt1p was eluted with 15 mls of 
elution buffer (1 M imidazole, 500 mM NaCl, 20 mM Tris-HCl [pH 7.9]).  All buffers 
contained 0.5 mM phenylmethylsulfonyl fluoride and 0.1% Trition X-100.  The eluant 
was dialyzed twice for three hours against two liters of 500 mM NaCl, 2 mM EDTA, 50 
mM Tris [pH 8.0], after which the protein was concentrated 10-fold by placing the 
protein solution in a dialysis bag and placing the bag on polyvinlypryollidine (PVP, 
molecular weight = 360,000). The protein solution was next dialyzed against a reaction 
buffer (150 mM NaCl, 25 mM Tris [pH 8.0], 2.5 mM CaCl2, 0.1% β-mercaptoethanol, 
10% glycerol).  Aliquots of purified Hmt1p fusion proteins were resolved on a SDS-12% 
PAGE gel to determine purity (see Fig 4.3).   
The same procedures were used to purify the His-tagged wild type and Arg→Lys 
substituted mutant GAR peptides (amino acids 628-733 of the full length protein), except 
that the final dialysis buffer was 500 mM NaCl, 50 mM Tris [pH 8.0].  Final protein 
concentrations were determined using a modified Lowry assay with BSA as the standard 
(Markwell et al., 1978).   
In vitro [3H]-SAM Methylation Assay 
Approximately 100 ng of purified recombinate His-Hmt1p was incubated with 1 
µg of wild type or 3 µg of mutant His-tagged GAR peptides in the presence of 30 µM  
S-adenosyl-L-[methyl- 3H]methionine (SAM) with a specific activity of 14.7 Ci/mmol 
(Amersham, Piscataway, NJ). The methylation reaction was carried out at 30° C in 50 








Figure 4.3 Coomassie stained SDS-PAGE displays purified recombinate Hmt1p. Lane 1 is
purified GST-Hmt1p. The GST tag was cleaved from GST-Hmt1p using thrombin (lane 2). The
upper band in lane 2 is Hmt1p. The lower band in lane 2 is the cleaved GST tag and thrombin
co-migrating together Lane 3 contains the His-tagged version of Hmt1p. Protein molecular
weight markers are indicated on the left.
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concentrated SDS-gel sample buffer was added, and the samples were boiled for 5 
minutes to stop the reaction.  A mock reaction using the wild type peptide contained 
everything except His-Hmt1p.  The samples were resolved on a SDS-10% PAGE.  
Following electrophoresis the gel was stained with Coomassie Blue and then 
fluorographed with Enhance (New England Nuclear, Boston MA), dried, and exposed to 
Kodak high speed X-ray film overnight. 
In Vitro Translation of Wild Type, Arg→Lys Substituted, and ∆GAR Nucleolin. 
 pBK-CMV (Stratagene, La Jolla, CA) containing myc-tagged wild type nucleolin, 
the myc-tagged Arg→Lys substituted mutant, or the myc-tagged ∆GAR nucleolin cDNAs 
was digested with Sma I to yield linear templates for in vitro transcription.  The linear 
templates were gel purified by phenol:chloroform extraction followed by ethanol 
precipitation.  Capped messenger RNA was in vitro transcribed using Ambion’s T7 
mMessage Machine kit following the manufacture’s recommended protocols.  The in 
vitro transcription reactions were treated with RNase-free DNase I supplied with the kit 
to remove the DNA template.  Transcribed messenger RNA was phenol:chloroform 
extracted and ethanol precipitated.  An aliquot of the capped mRNA was resolved on a 
discontinuous 1.5% agarose:formaldehyde gel to asses the quality and quantity of the 
RNA.  Roughly equivalent amounts of the capped mRNAs were added to translation 
competent rabbit reticulocyte lysates (Promega Corporation, Madison, WI).  Translation 
reactions were preformed according to the manufacture’s recommended protocols, except 
that 1 µl of 1 mM unlabeled methionine was substituted for the required [35S] labeled 
methionine.  The translation reaction was mixed with an equal volume of 1 x low SDS-
sample buffer (1.3% SDS) without β-mercaptoethanol or dithiothreitol (DTT). Samples 
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were heated at 94°C for 90 seconds before loading on a 1.5 mm, SDS-10% PAGE 
(Hoeffer Mighty Small gel, rig model number SC250 size 8 X 10 cm, Amershan 
Biosciences Buckinghamshire, England).  Electrophoresis was performed for 1.5 hours at 
150 volts.  The gel was transferred to nitrocellulose (Millipore Bedford , MA) using a 
standard tank buffer system. The proteins were transformed to the nitrocellulose for three 
hours at a constant 0.5 amps.  Transfer of the proteins was confirmed by the presence of 
pre-stained protein markers (Gibco-BRL Life Technologies, Gaithersburg, MD).  The 
nitrocellulose blot was immediately placed in pre-binding buffer (25 mM  NaCl, 10 mM  
MgCl, 10 mM  HEPES (pH-8.0), 1.0 mM EDTA (pH-8.0),1 mM DTT, 5% Carnation 
non-fat dry milk) for 1.5 hours at room temp with shaking.  A random primed DNA 
probe was prepared using Rsa I fragments of pBR322.  The DNA probe had a specific 
activity of 1.3 X 105 CPM/µl.  The blot was then transferred to binding buffer (50 mM 
NaCl, 10 mM MgCl2, 0.1 mM EDTA, 1.0 mM DTT, 10 mM HEPES, 0.25% Carnation 
non-fat dry milk) and incubated with a 4.5 X 105 counts of a [32P] labeled DNA probe for 
1.5 hours.  The blot was lightly dried for 45 minutes in a vacuum oven set at 60°C, before 
affixing it to 3MM chromatography paper (Whatman, Fairfield, NJ).  The blot was then 
covered with plastic wrap and exposed to a phosphor screen for 24 hours.  The phosphor 
screen was read using a Storm phosphoimager (General Dynamics, Buckinghamshire, 
England).  The nitrocellulose blot was re-wetted with 1 x PBS and pre-blocked in 3% 
Carnation non-fat dry milk in 1x PBS for one hour.  The blot was then incubated for one 
hour in mouse anti-myc mAb 9E10 hybridoma supernatant followed by five washes in 1 x 
PBS.  The blot was incubated with a 1:3000 dilution of goat anti-mouse monoclonal 
antibody coupled to horseradish peroxidase in 10% horse serum for one hour followed by 
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three washes in 1 x PBS.  The blot was developed using 4-chloro-1-napthaol as the 
chromogenic reagent. 
Expression of the Arg→Lys Substituted Hamster Nucleolin in HeLa Cells  
HeLa cells were grown on coverslips in six well culture plates at 37°C in a 5% 
CO2 atmosphere.  The cells were grown in Dulbecco’s Modified Eagle Medium (DMEM) 
(Life technologies Gibco BLR, Gaithersburg, MD) supplemented with 10% fetal calf 
serum and 50 µg/ml gentamycin.  HeLa cells were transfected with pBK-CMV 
expression vectors carrying either cDNAs encoding myc-tagged wild type hamster 
nucleolin or the Arg→Lys mutation.  Transient transfection was preformed as described 
in Chapter 2.  Cells were hypotonically shocked for 15 minutes using 0.15 x PBS 
(Zatsepina et al. 1997), and then allowed to recover from the shock for up to 2 hours in 
normal growth conditions (DMEM with 10% FCS at 37°C in 5% CO2) after which all 
cells were fixed and prepared for microscopy as described previously. 
RESULTS 
In Chapter 3 methyltransferase inhibitors (MTA and DAA) caused a change in the 
sub-cellular localization of exogenously expressed nucleolin.  MTA and DAA, however, 
block all SAM dependent cellular methylation, including DNA methylation, RNA 
methylation, and protein methylation.  The redistribution of nucleolin may, therefore, not 
be directly correlated to its methylation state. We set out to directly test the possibility 
that methylation of nucleolin’s GAR domain is necessary for nucleolar association. 
Generation and In Vitro Methylation of a Lysine Substituted GAR Domain 
 A Chinese hamster nucleolin cDNA subclone, consisting of amino acids 650-733 
was ligated into pBluescript and used for PCR-based oligonucleotide site directed 
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mutagenesis.  All ten arginines within the GAR domain were changed to lysine.  In 
addition to generating the fully substituted nucleolin, the technique also yielded a series 
of partially substituted nucleolins.  This series was originally designed to test the effect of 
degrees of methylation if the fully substituted protein displayed a distinct phenotype. The 
changes were confirmed by dideoxy sequencing (see Fig. 4.2). The conservative change 
to lysine maintains the relative charge and size of the side chain.   
Like the terminal guanido nitrogens of arginine, the ζ-nitrogen of lysine can be 
post-translationally methylated.  However, lysines were observed not to be methylated 
under conditions permissive for arginine methylation (see below).  To confirm that the 
fully substituted Arg→Lys GAR domain of nucleolin was not a substrate for post-
translational enzymatic methylation, a recombinate His-tagged version of the protein 
arginine methyltransferase from Schizosaccharomyces cerevisiae, Hmt1p, was purified 
for use in in vitro methyltransferase assays (see Fig. 4.3).   
Wild type and the fully Arg→Lys substituted carboxy terminal domains of 
nucleolin (amino acids 628-733) were expressed in E. coli as amino terminal His-tagged 
fusion proteins.  The peptides were affinity purified using Ni2+ columns.  Peptides were 
incubated with Hmt1p in the presence of S-adenosyl-L-[methyl-3H]-methionine as the 
methyl donor.  The wild type peptide is readily methylated by Hmt1p (see Fig. 4.4, panel 
B, lanes 1 and 2).  The mutant peptide, however, shows no detectable signal (see Fig. 4.4, 
panel B, lanes 3 and 4) even though it is present in four-five times the quantity of the 
wild type peptide (see Fig. 4.4, panel A, lane 3 and 4).  A mock reaction containing the 
wild type peptide incubated in the presence of [methyl-3H]-SAM without Hmt1p, showed 
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Figure 4.4 Hmt1p methylation of wild-type and the fully lysine substituted GAR peptides.
Panel A is a Coomassie stained PAGE-gel. Panel B is the autoradiogram of panel A. Wild type
and lysine substituted peptides were expressed in as His-tagged peptides. The wild type
and mutant peptides were incubated with recombinate Hmt1p and S-adenosyl-L-[methyl-
methionine ([methyl- SAM) (wild type lanes 1and 2, mutant lanes 3 and 4). The wild-
type peptide was also incubated with [methyl- H] SAM alone (lane 5). Approximately 4-fold
more lysine substituted mutant peptide (Panel A lanes 2 and 3), was present compared to the
wild type peptide (Panel A lanes 1 and 2). Only the wild-type peptide was methylated (Panel B
lane 1 and 2). The wild-type peptides ability to be labeled was dependant on the presence of
Hmt1p since no signal was detected when the wild-type peptide was incubated with [methyl- H]
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Figure 4.5 Southwestern binding assay of -tagged wild type nucleolin, the lysine substituted
protein and GAR nucleolin. Panel A is a immuno-blot against the tags. The right facing
arrow indicates full length
Wild type nucleolin and the
mutant protein bound radiolabeled DNA ( . Although GAR
nucleolin was approximately 10-20 fold wild type protein, it
exhibited no nucleic acid binding above background . Lane four is a control to
account for lysate proteins. An endogenous nucleic acid binding protein co-migrated with
GAR, and likely accounting for the smeared signal (panel B, lane 3).
myc
myc-
nucleolins (Panel A, lane 1). The left facing arrow indicates GAR
nucleolin. Panel B is the autoradiogram of the blot in Panel A.
Panel B, lanes 1and 2, respectively)
(panel A, lane 3) in excess over
(panel B, lane 3)
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endogenous methylation activity, and methylation of the wild type peptide is dependant 
only on the presence of Hmt1p.  Taken together, these results show that the lysine 
substituted mutant is not a substrate for RGG specific methyltransferase, Hmt1p. 
Nucleic Acid Binding Ability of Wild Type, Arg→Lys Substituted, and ∆GAR 
Nucleolin 
 
Messenger RNA encoding myc-tagged wild type, lysine substituted, and ∆GAR 
nucleolins were expressed separately in rabbit reticulocyte lysates.  The expressed 
proteins were transferred to nitrocellulose.  The blot was incubated with non-specific 
[32P]-labeled double-stranded DNA.  Slightly more mutant protein was produced than 
wild type (see Fig. 4.5, lanes 1 and 2).  The GAR truncated nucleolin was in excess of the 
wild type protein by approximately 5-10 fold (Fig. 4.5, lane 3). Lane 4 in Figure 4.5 is a 
control to account for endogenous translation products; no mRNA was added.  
Quantification of the radioactive signals associated with the wild type and mutant 
proteins shows that the mutant signal was approximately 10% stronger than the wild type 
signal (Fig. 4.5, panel B, lanes 1 and 2).  The ∆GAR nucleolin co-migrated with an 
endogenous nucleic acid binding protein.  Therefore, the nucleic acid binding of ∆GAR 
could not be quantified.  It appears from the autoradiogram, however, that the ∆GAR 
signal was equivalent of background (Fig 4.5, panel B, lanes 3 and 4).    
Expression of the Fully Substituted Arg→Lys Nucleolin in Interphase HeLa Cells 
Chapter 2 demonstrated that the GAR domain of nucleolin was necessary for 
nucleolar localization.  Arginines located within the GAR domain have been shown to be 
post-translationally dimethylated (Lischwe et al., 1981; Lischwe et al., 1982).  When 
cellular methylation was blocked using methyltransferase inhibitors, nucleolin underwent 
a rapid redistribution from nucleoli to the nucleoplasm in interphase cells.  This result is 
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consistent with results showing the mis-localization of HMW FGF2 and hnRNP A2 when 
their methylation was blocked by the same inhibitors.  Blocking methylation redistributed 
HMW FGF2 and hnRNP A2 from the nucleus to the cytoplasm (Pintucci et al. 1996; 
Nichols et al., 2000).  In addition, reviews on nucleolin suggest that methylation may 
play a role in its localization to nucleoli (Ginisty et al. 1999).  A version of nucleolin 
which could not be mthylated was used to directly test the question: is methylation 
necessary for proper localization?  
Full-length, myc-tagged, wild type and Arg→Lys substituted nucleolin was 
expressed in HeLa cells by transient transfections.  The fully substituted nucleolin 
properly localized to interphase nucleoli as determine by antibody staining (see Fig. 4.6, 
A and B).  The staining pattern and nucleolar morphology was indistinguishable between 
cells expressing the wild type protein and the fully substituted protein.   
Exposing cells to hypotonic conditions causes disassembly of interphase nucleoli.  
Hypotonically shocked cells redistribute their nucleolar components to the nucleoplasm 
(Zatsepina et al., 1997).  Zatsepina et al. (1997) demonstrated that return of cells to 
normal osmotic growth conditions after hypotonic shock causes nucleoli to reform.  The 
process of reforming nucleoli is accompanied by the appearance of discrete 
extranucleolar bodies, that are very similar to pre-nucleolar bodies  (PNBs) observed in 
teleophase of mitosis.   
HeLa cells expressing wild type and Arg→Lys substituted nucleolin were 
hypotonically shocked to cause disassembly of interphase nucleoli.  The behavior of the 
transfected nucleolins were monitored as nucleoli reformed (Fig. 4.6, C-F).  Both proteins 














HeLa cells were transfected with cDNAs encoding -tagged fully lysine
substituted Chinese hamster nucleolin. The -tagged lysine substituted mutant nucleolin
localized to interphase HeLa cell nucleoli ( and ). The transfected cells were subjected to 15
minutes of hypotonic shock in 0.15 x PBS, causing a breakdown of the interphase nucleoli and
redistribution of the lysine substituted mutant nucleolin ( and ). After one hour of recovery in
fresh medium, the lysine substituted mutant nucleolin is observed in pre-nucleolar bodies (arrow
in ) and reforming nucleoli ( ). Nucleoli had fully reformed after two hours of recovery and
the lysine substituted mutant nucleolin had reassociated with the nucleoli ( and ).





nucleoli (see Fig 4.6, G-J).   The behavior and kinetics of reassembly of nucleoli between 
the wild type nucleolin and Arg→Lys substituted protein were indistinguishable, thus 
demonstrating that early associations of nucleolin with other nucleolar proteins and 
partial processed pre-rRNA in the absence of rDNA are unaffected by the substitution of 
lysine for arginine in the GAR domain of hamster nucleolin.   
DISCUSSION 
The results of Chapter 3 suggest that methylation may play an important role in 
the sub-cellular localization of nucleolin.  This possibility is based on results obtained 
using methyltransferase inhibitors to inhibit SAM-dependent cellular methylation.  
However, such inhibitors are not only blocking arginine methylation, but also DNA 
methylation, RNA methylation and other forms of protein methylation.  The effects seen 
with these methyltransferase inhibitors may not be directly related to blocking 
methylation of the target protein, but instead the consequence of interfering with other 
cellular targets.  It is important to determine if the in vivo effects observed using 
methyltransferase inhibitors are directly related to arginine methylation of the GAR 
domain of nucleolin.  In order to determine this, a version of nucleolin that would not be 
methylated was generated. 
All ten arginine residues present within the GAR domain of Chinese hamster 
nucleolin were changed to lysine.  Of the twenty basic amino acids, the side chain of 
lysine is the closest in size and charge to that of arginine.  The intrinsic pKa of the amino 
group in the lysine side chain is 11.1 compared to a pKa value of about 12 for the 
guanido nitrogens of arginine.  Lysine is more chemically reactive under physiological 
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conditions due to having a higher percentage of nonionized side chains, which are potent 
nucleophiles compared to the arginine guanido group.   
The ζ-nitrogen of lysine can be post-translationally mono- or dimethylated in 
vivo.  An in vitro methylation assay was used to determine if lysine in the context of a 
RGG domain would be recognized as a substrate for RGG-specific protein arginine 
methyltransferases.  The yeast, Schizosaccharomyces cerevisiae, appears to have only 
one protein arginine methyltransferase, Hmt1p.  All the known RGG containing proteins 
in yeast are substrates for this enzyme, indicating that it is able to recognize a broad range 
of RGG-containing substrates (Henry and Silver, 1996; Lin et al., 1996).  In vertebrates, 
there are six different genes that encode protein arginine methyltransferases, five of 
which catalyze the formation of aDMA.  The existence of multiple protein arginine 
methyltransferases in vertebrates indicates a much higher level of specificity than exists 
in yeast, which contains the one protein arginine methyltransferase (Frankel and Clarke, 
2000; Tang et al., 2000; Frank et al., 2001; Rho et al., 2001).  If Hmt1p is unable to 
methylate lysine in the KGG motifs of the lysine substituted nucleolin GAR domain, then 
it is highly unlikely that any of the more specific protein arginine methyltransferases of 
vertebrates would be able to methylate the lysine residues in the KGG motifs. 
A peptide of the wild type GAR domain proved to be an excellent substrate for 
the protein arginine methyltransferase, Hmt1p, as determined by radiolabel incorporation 
of the methyl group from S-adenosyl-L-[methyl-3H]-methionine.  The lysine substituted 
peptide, however, was not a suitable substrate for Hmt1p (see Fig. 4.4).  The wild type 
peptide showed no detectable signal without the presence of Hmt1p, indicating that 
methylation is dependant on the presence of Hmt1p (see Fig 4.4).  These results 
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demonstrate that lysine in the context of a KGG motif is not a substrate for Hmt1p, and 
therefore unlikely to be a substrate for any of the more substrate-specific vertebrate 
protein arginine methyltransferases. 
   Removal of nucleolin’s GAR domain greatly reduces nucleolin’s nucleic acid 
binding ability.  The nucleolar localization of nucleolin is thought to be due to functional 
association with nucleolar components, probably via its interaction with pre-rRNA.  
Therefore, it was important to determine the affects of the lysine substitutions on nucleic 
acid binding.  A Southwestern binding assay was preformed using wild type, ∆GAR, and 
the fully substituted Arg→Lys nucleolins.  All three proteins were expressed in rabbit 
reticulolysates.  Nucleolin lacking its GAR domain failed to bind nucleic acids (see Fig 
4.5, lane 3) in this assay supporting previous results (Heine et al., 1993).  The lysine 
substituted nucleolin was able to bind nucleic acids in a Southwestern binding assay (see 
Fig 4.5, lane 2).  This is somewhat surprising, because Raman et al. (2001) showed that 
in vitro synthesized KGG peptides exhibited 20-50 fold lower nucleic acid binding as 
compared to RGG peptides.  Their study, however, used a small peptide corresponding to 
a portion the GAR domain from human nucleolin, and it may not reflect the behavior of 
GAR domains in the context of the full length protein with the four upstream RBDs. 
The GAR domain is thought to modulate nucleolin’s interaction with nucleic 
acids by disrupting secondary structure of the RNA, thus allowing access for the RDBs 
(Ghisolfi et al.,1992a; Hanakah et al., 2000).  The exact mechanism of the GAR domain’s 
ability to perturb RNA superstructure is not known.  This function may not be disrupted 
by the substituted lysines, allowing for normal nucleic acid binding.  This possibility is 
supported by the fact that the KGG peptides behaved identically to aDMA (RGG) 
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containing peptides with respect to their ability to perturb nucleic acid superstructure, 
which is remarkably different from the unmethylated peptide (Raman et al., 2001).  The 
guanido group of arginine is planar as a result of resonance.  Dimethylation of one of the 
nitrogens would result in a decrease in this resonance, and therefore, a loss of the planar 
configuration.  This would cause the unmethylated nitrogen to resemble the amino group 
of lysine.  In addition, dimethylation would reduce the number of hydrogens available for 
hydrogen bonding, and the available geometries for hydrogen bonding to the same as that 
of lysine (Raman et al., 2001).  For these reasons, the lysine substituted nucleolin may 
behave in a similar manner to aDMA-containing nucleolin. 
KGG and aDMA containing RGG peptides are known to modify nucleic acid 
conformation in a similar manner.  If the sub-cellular localization is a function of the 
GAR domain’s ability to perturb nucleic acid structure, lysines may preserve this 
function by mimicking the behavior of the aDMAs. 
 The lysine substituted nucleolin localized properly to interphase HeLa cell 
nucleoli (see Fig 4.6, A and B).  The lysine substituted nucleolin was redistributed to the 
nucleoplasm by hypotonic shock, just as did the wild type protein.  The behavior and 
kinetics of nucleolar reassembly was indistinguishable between cells expressing wild type 
nucleolin and the fully substituted protein.  This result demonstrates that early 
associations of the Arg→Lys substituted protein with nucleolar RNAs or other proteins in 
the absence of rDNA are not affected (see Fig. 4.6, C-H).   
The localization of the lysine substituted nucleolin disagrees with the results of 
the methyltransferase inhibitors presented in Chapter 3.  The lysine substituted nucleolin 
is not a substrate for a RGG specific protein arginine methyltransferase, indicating that it 
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cannot be methylated in vivo (see above).  The lysine substituted nucleolin was able to 
bind nucleic acids as determined by a Southwestern assay (see Fig. 4.5).  The proper 
localization of the unmethylated, lysine-substituted nucleolin demonstrates that arginine 
methylation is not involved in the sub-cellular localization of nucleolin.  The fact that the 
unmethylated lysine substituted nucleolin behaves normally in vivo, indicates that the 
redistribution of nucleolin in the presence of methyltransferase inhibitors, presented in 





Summary, Conclusions and Future Directions 
 Nucleolin was first described almost 30 years ago by Orrick et al. (1973) and its 
cDNA was cloned 17 years ago by Lapeyre et al. (1985).  Since its first discovery, 
nucleolin has been implicated in a wide array of functions including rDNA transcription, 
pre-rRNA processing, ribosome assembly, nucleocytoplasmic transport, immunoglobulin 
gene switching, telomeric DNA association, insulin response, glucocorticoid receptor 
function, and transcription regulation (Csermely et al. 1993; Hanakahi et al., 1997; Nisole 
et al. 1999; Pollice et al., 2000; Schulz et al., 2001; Tuteja and Tuteja, 1998; Ginisty et 
al., 1999; Erard et al., 1988; Borer et al., 1989; Herrera and Olson, 1986; Bouvet et al., 
1998).  Nucleolin’s primary function, however, is related to ribosome biogenesis (see 
Chapter 1).  Nucleolin’s role in ribosome biogenesis puts it at the heart of one of the cells 
most important activities.  The nucleolus is proving to be “plurifunctional” and more than 
just a ribosome factory, with roles in post-translational modification and 
ribonucleoparticle assembly of non-ribosomal RNAs, gene silencing, aging and cell cycle 
control (Pederson, 1998b; Dundr and Misteli, 2001).  These may be reasons why 
nucleolin is apparently involved in so many diverse cellular processes. 
This dissertation demonstrates the requirement of the glycine-arginine-rich (GAR) 
domain for proper in vivo localization of hamster nucleolin.  Nucleolin lacking the 
carboxy terminal GAR domain fails to localize to interphase nucleoli.  Instead, it 
accumulates within the nucleoplasm (see Fig. 2.2).  The nucleoplasmic localization of 
∆GAR was then used as a novel probe to test for interactions with other nucleolar 
proteins.  Nucleolar proteins Nopp140 and fibrillarin showed little or no interaction with 
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∆GAR.  B23, however, redistributed to the nucleoplasm in the presence of ∆GAR (see 
Figs. 2.3-2.5).  This suggests that B23 associates with ∆GAR nucleolin in vivo.  This 
result is consisted with the interaction observed between nucleolin and B23 as determined 
by a yeast two hybrid assay and immuno-precipitation (Li et al., 1996). 
The nucleolar accumulation of nucleolin is apparently the result of a complex 
interplay between several domains.  RNase treatment induces the release of nucleolin 
from nucleoli in A6 cells confirming that nucleolin’s localization at least requires the 
presence of RNA (Schwab and Dreyer, 1997).  The RNA-binding domains (at least one) 
are required for nucleolar localization, but they are unable by themselves to target hybrid 
proteins to the nucleolus (Creancier et al., 1993).  In conjunction with the RBDs, the 
GAR domain of nucleolin is also required for nucleolar localization, but it too cannot 
separately target a hybrid protein to the nucleolus (Heine et al., 1993; Schmidt-Zachmann 
and Nigg 1993; Creancier et al., 1993).  In the case of the yeast protein, Nsr1, the N-
terminal acidic / basic domain was able to direct a β-galactosidase fusion to yeast 
nucleoli (Yan and Mélèse, 1993).  This however, was not the case for the homologous 
region of vertebrate nucleolin (Schmidt-Zachmann and Nigg 1993; Creancier et al., 
1993).  So differences exist between the vertebrate and yeast “homologs”. 
The GAR domain of nucleolin consists several RGG the tripeptide motifs.  It is 
repeated 10 times with interspersed aromatic amino acids (see Fig. 1.4).  RGG motifs 
containing aDMAs are found in a number of RNA binding proteins (see Chapter 1).  At 
least eight, and possibly all ten arginines in the RGG motifs are post-translational 
dimethylated in vivo (Lischwe et al., 1985; Lapeyre et al., 1986).  The functional 
significance of arginine dimethylation in nucleolin is unknown.   
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Asymmetric dimethylation eliminates the planarity of the guanido group of the 
arginine side chain.  The remaining unmethylated nitrogen would then resemble the 
amino group of lysine with the same number of hydrogen atoms available for hydrogen 
bonding.  Evolution, however, has maintained arginines and not lysines in GAR domain-
containing proteins from yeast to man.  The high metabolic cost of arginine methylation 
(12 ATP per methylation event) would be eliminated by natural selection, unless it 
provided a needed function (Gary and Clarke 1998).  Methylation does not change the 
overall charge of the RGG domain, but the addition of the bulkier methyl groups may 
modulate protein-protein interaction or protein-nucleic acid interactions (Tao and 
Frankel, 1992; Liu and Dreyfuss, 1995; Raman et al., 2001; Friesen et al., 2001).  Since 
the GAR domain of nucleolin is known to be involved in the nucleolar localization and 
nucleic acid binding of nucleolin, we decided to explore what, if any role asymmetric 
arginine dimethylation would play in these activities. 
The methyltransferase inhibitors 5-deoxy 5′ methythioadenosine (MTA) and 3-
deaza-adenosine (DAA) redistributed exogenously expressed nucleolin from nucleoli to 
the nucleoplasm in transfected HeLa cells (see Fig. 3.2).  Nucleolin redistribution due to 
MTA was reversed upon removal of the methyltransferase inhibitor.  The reassociation of 
nucleolin with nucleoli upon MTA removal was equally as rapid, taking as little as 1 hour 
(see Fig 3.3).  Protein synthesis was blocked to determine if the affects observed with 
MTA could be the result of newly synthesized, unmethylated nucleolin entering the 
nucleus, but simply unable to associate with nucleoli.  Myc-tagged nucleolin accumulated 
in the nucleoplasm in an identical manner in the presence of MTA when protein synthesis 
was blocked using cycloheximide (see Fig. 3.3).  This suggests that nucleolin already 
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localized to nucleoli prior to MTA exposure redistributed to the nucleoplasm, and that the 
nucleolar localization of nucleolin may be dependent on arginine methylation.   
The possibility that nucleolar localization of nucleolin may be dependent on 
arginine methylation is supported by the role of arginine dimethylation in HMW-
fibroblast growth factor and hnRNP A2.  Both proteins have been shown to change their 
sub-cellular localization from nuclear to cytoplasmic in the presence of methyltransferase 
inhibitors, MTA and DAA (Pintucci et al., 1996; Nichols et al., 2000).        
Another nucleolar protein, fibrillarin, did not redistribute in the presence of MTA 
(see Fig 3.2).  This is somewhat surprising since fibrillarin contains a GAR domain that is 
highly methylated in vivo (Christensen and Fuxa, 1988).  The differences in the behavior 
of nucleolin and fibrillarin in the presence of MTA may reflect distinct functional 
differences between their respective GAR domains (see Chapter 3).  The redistribution of 
nucleolin in the presence of the methyltransferase inhibitors, therefore, may not be 
correlated to its methylation, but rather to inhibiting methylation of another substrate, 
possibly pre-rRNA (see Chapter 3).   
 To directly test the possibility that methylation of nucleolin’s GAR domain is 
necessary for nucleolar association, all ten arginines wihtin the GAR domain of Chinese 
hamster nucleolin were substituted with lysine (see Fig 4.1).  The protein arginine 
methyltransferase from Schizosaccharomyces cerevisiae, Hmt1p, was purified for use in 
an in vitro methyltransferase assay.  Hmt1p is the sole Type I protein arginine 
methyltransferase in Schizosaccharomyces cerevisiae, and it is therefore able to 
recognize and methylate a broad range of substrates (see Chapter 4).  Hmt1p was able to 
efficiently methylate the wild type GAR peptide (see Fig. 4.4, lanes 1 and 2).  The fully 
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substituted GAR peptide, however, was not a substrate for Hmt1p (see Fig 4.4 lanes, 3 
and 4).  The results indicate that the amino nitrogen of lysine is not a substrate for protein 
arginine methylation in vivo. 
The nucleolar localization of nucleolin is thought to be due to functional 
association with nucleolar components, namely pre-rRNA.  To determine the affect of the 
Arg→Lys substitution on nucleic acid binding, a Southwestern assay was preformed.  
Both the lysine substituted protein and the wild type nucleolin were demonstrated to bind 
nucleic acids to roughly equivalent extents (see Fig 4.5).  ∆GAR nucleolin, however, 
failed to bind nucleic acids in this assay (see Fig 4.5) supporting previous results (Heine 
et al., 1993). 
The Arg→Lys substituted protein was able to properly localize to interphase 
nucleoli when transiently expressed in HeLa cells (see Fig. 4.6).  When nucleoli were 
disrupted by hypotonic shock, the Arg→Lys substituted protein reassembled with 
behavior and kinetics indistinguishable from that of cells expressing wild type nucleolin 
(see Fig. 4.6). The proper localization of the unmethylated, lysine-substituted nucleolin 
argues against the process of methylation being involved in the sub-cellular localization 
of nucleolin. 
To understand the methyltransferase inhibitor results, it will be crucial to 
determine the effects of the methyltransferase inhibitors on cellular activities including 
pre-rRNA synthesis.  The methyltransferase inhibitors resemble adenosine, and may 
therefore, be very toxic to the cell by inhibiting ATP-dependent events.  Determination of 
the specificity and enzymology of these compounds (MTA and DAA) needs to be 
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addressed before data resulting from their use can be interpreted correctly and with 
confidence. 
Arginine methylation is often associated with RNA-binding and no clear 
examples of the effect of arginine methylation in the context of fully methylated full-
length protein have been examined.  For this reason it would be of great benefit to 
precisely determining the binding of methylated and unmethylated wild type nucleolin as 
well as the lysine substituted protein to nucleolin’s high affinity in vivo RNA binding 
sites (NRE).  In addition to the methylation of the protein it is also possible that pre-
rRNA must be methylated on its sugar to allow nucleolin to correctly interact with pre-
rRNA in vivo.   
Unfortunately, production of the unmethylated form of nucleolin requires 
production in prokaryotes which lack protein arginine methyltransferase activity.  Despite 
great effort by myself and others, no one has yet successfully produced recombinate 
hamster nucleolin in great abundance due to its extreme cytotoxicity and instability.  
Perhaps the use of cell-free bacterial lysates systems or expression in the newly created 
type I methyltransferase minus background in yeast may be able to produce usable 
amounts of protein (Zobel-Thropp et al., 1998).  The instability of recombinate nucleolin 
may be related to the lack of post-translational medications, namely phosphorylation and 
methylation.  Examining the effects of these post-translational modifications on nucleolin 
stability or targeted degradation may reveal one of their possible functions. 
One obvious question not yet answered relating to nucleolin’s arginine 
methylation is where and when does nucleolin methylation take place?  The most likely 
candidate for arginine methylation in vertebrates is PRMT1, which is primarily located in 
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the nucleus.  If the post-translational methylation of nucleolin is irreversible, then why 
should the protein arginine methyltransferase be nuclear, unless the temporal control of 
methylation is important and the nascent protein is not immediately methylated after 
translation in the cytoplasm.  Pulse chase experiments could be used to determine the 
timing of methylation of nucleolin in vivo. 
As interest in protein arginine methylation grows, so does the understanding of its 
importance to cellular function.  The number of known substrates for protein arginine 
methylation is ever increasing.  Models for the function of arginine methylation in 
nucleolin will improve as new and novel roles of arginine methylation in other proteins 
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pET 30a GAR WT MCS
MCSMCS
MCS
A Fig. 1. Vector maps of wild type and Arg Lys substituted GAR domains from hamster nucleolin. The circular map represents the
prokaryotic expression vector pET30a (5422 bp) containing subclones of the GAR domain. The enlarged area is the multiple cloning




Appendix A: Vector Maps
EcoR I
EcoR I





























































B Fig. 2. Vector maps of 21R constructs (hamster nucleolin in -6-D). The circular map represents pBluescript SK (2961
bp) with one of the hamster nucleolin subclones. The enlanged area is the multiple cloning sequence (MCS) containing either

























A Fig 3. Vector maps of in pET 30a. The circular map represents the prokaryotic expression vector pET30a (5422 bp)









































































A Fig 4. Vector maps of pBK-CMV hamster nucleolin constructs. The circular map represents pBK-CMV (4512 bp) with various
-tagged nucleolin constructs. The enlarged area is the multiple cloning sequence (MCS) containing either wild type or Arg Lys
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A Fig. 5 Vector maps of pEGFP-N3 ( GAR and WT) used to generate stably transfected CHO cells lines. The circular map
represents pEGFP-N3 (4700 bp) with either wild type or GAR hamster nucleolin. The enlarged area is the multiple cloning
































































Products From the First PCR Reaction
Were Used For a Second PCR Reaction  
B Fig 1.  The resulting PCR product was  heterogenous DNA containing only one series of 
mutations in a given strand.  The hybrid PCR product was subcloned into back into myc-6-D 
using Nco1 and EcoR1 restriction sites..  When the resulting plasmid was proprogated in E. coli 
the mismatched based were recognized and repaired by the cell.  Each mismatch had a chance 
of being converted to the matching base of the opposite stand.  Sites 1, 2, and 5 were changed to 
the wild type sequence and sites 3 and 4 were changed to the mutated sequence.  This construct 
was named 21R CHO GAR B. 
PCR product cloned and 


























Appendix B: PCR Strategy
21R CHO GAR WT



















































21R CHO GAR B
21R CHO GAR B/D
21R CHO GAR B/D
21R CHO GAR A/B/D
Appendix B Fig 2. PCR strategy used to generate the A and D series of arginine to lysine
substitutions. The 21R CHO GAR B/D PCR product was subcloned using BsmA1
































































































B Fig 3. PCR strategy employed for generation of the C series of arginine to lysine
substitutions. Primer T7 was added to the PCR reaction after 15 cycles to create a fully
substituted product that included a useable restriction site for cloning purposes. The reaction
also created DNAs with wild type sequences at the C position. Clones were sequenced to
identify a fully substituted clone. The fully substituted clone was named 21R CHO GAR
A BCD .2 2
21R CHO GAR A/B/D
21R CHO GAR A BCD2 2
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13587 Honey Drive 
Baton Rouge, LA 70810 
 
         March 19, 2002 
 
Dear Mr. Pellar, 
 
 I hereby give you, Gregory James Pellar, permission to use figure 1.2 from my 
dissertation entitled “Two Splice Variants of Nopp140 in Drosophila melanogaster” 
(Copyright registration # TX 5-444-537) for use in your dissertation entitled “The Post-






John M. Waggener, Ph.D. 
 144 
Vita 
Gregory James Pellar attended the University of Mississippi in Oxford, Mississippi, and 
graduated in the spring of 1994 with a Bachelor of Science degree in biology.  After 
living in Shreveport, Louisiana, for one year, he entered the graduate program in the 
Department of Biochemistry at Louisiana State University in Baton Rouge, Louisiana, in 
the fall of 1995.  His life in Baton Rouge was highlighted by the birth of his son Geoffrey 
James Pellar in 2001.  Mr. Pellar will graduate with the degree of Doctor of Philosophy in 
biochemistry from Louisiana State University in May, 2002. 
